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Abstract 
The use of alcohol and drugs is a significant issue faced by First Nations communities in Canada, 
which is accentuated by high rates of mortality and morbidity resulting from opioid use. The 
frequency of opioid-related emergency room visits and the higher prevalence of illicit 
prescription drug use disorders in First Nations populations suggest challenges. Methadone 
maintenance therapy programs are consistently found to be the most effective treatment for 
opioid dependence; however, due to financial, geographic, and cultural factors, Aboriginal 
individuals are less likely to initiate methadone maintenance therapy. Cree Nations Treatment 
Haven is the first on-reserve methadone maintenance therapy program in Canada and the present 
study aimed to evaluate this program from clients’ perspectives. Results indicated that 
individuals in treatment with higher rated improvement showed greater engagement, life quality, 
psychological functioning, physical health, relationships with family and friends, and a more 
positive opinion of services and less motivation for treatment, psychological distress, problems 
with alcohol, criminality, employment and life difficulties, and overall risk. Individuals with a 
more positive opinion of services reported higher engagement and lower motivation. Finally, 
individuals in treatment reported a decrease in drug use, high-risk, and criminal behaviours, and 
improvements in housing, employment status, and family support, since admission to the 
program. Future evaluation would be beneficial to solidify the present findings and clarify the 
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Evaluating an On-Reserve Methadone Maintenance Therapy Program for First Nations Peoples  
 The use of alcohol and illegal drugs is a primary concern among First Nations populations 
in Canada (Currie & Wild, 2012; Elton-Marshall, Leatherdale, & Burkhalter, 2011). Eighty-two 
percent of First Nations people rate alcohol and illegal drugs as the most significant issue 
encountered by their community, coming before both housing (70.7%) and employment (65.9%; 
First Nations Information Governance Centre, 2011). The history of colonialism and assimilation 
that First Nations peoples have faced has led to serious health inequities (Reading & Wien, 2013) 
including the use of alcohol and illegal drugs. There is a need for culturally appropriate 
treatments to address these disparities in First Nations communities. 
 When compared to the non-First Nations population in Canada, First Nations peoples are 
more likely to use all types of illegal drugs and tend to start using substances at a much younger 
age (First Nations Centre, 2005). In addition, First Nations peoples are 2 to 4 times more likely 
to experience illicit prescription drug use disorders than the general population (Currie & Wild, 
2012; Elton-Marshall et al., 2011; Wardman, Khan, & el-Guebaly, 2002). First Nations peoples 
also experience greater rates of mortality due to drug overdose than the general population 
(Milloy et al., 2010). 
Use of Opioids in the General Population  
 There are approximately 50 million people globally who use opiates and opioids (United 
Nations Office on Drugs and Crime, 2014); opiates (e.g., heroin, morphine, and codeine) are pain 
relieving drugs derived specifically from naturally occurring alkaloids in the resin of the opium 
poppy, while opioids (e.g., oxycodone, hydrocodone, and methadone) include synthetic or 
manmade substances that have opiate-like effects (National Institute on Drug Abuse, 2011). The 
term opioid can be used to describe both natural and synthetic drugs that act on opioid receptors, 
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thus all opiates are opioids, but not all opioids are opiates. For example, heroin and morphine 
(produced with natural opium) can be classified as both opiates and opioids, while oxycodone 
and methadone (produced synthetically) can only be classified as opioids (National Institute on 
Drug Abuse, 2011). Aside from pain relief, opiates and opioids also offer anxiolytic, 
antidepressant, and antipsychotic effects, which make them commonly used drugs for self-
medication (Khantzian, 1997).  
 Illicit use of prescription opioids such as oxycodone now represents the most common 
and problematic category of opioids even when compared to heroin (Compton & Volkow, 2006), 
and prescription opioids are currently the most frequently misused drug class (Currie & Wild, 
2012). In the United States prescriptions for opioids have risen from 40 million in 1991 to 180 
million in 2007 (Substance Abuse and Mental Health Services Administration, 2007), and in 
2010 enough opioid pain relievers were prescribed to medicate every adult in the United States 
with the equivalent of 5-mg of hydrocodone every 4 hours for 1 month (Centers for Disease 
Control, 2013). However, the United States is not the only country prescribing large amounts of 
opioids. Between 2007 and 2009 Canada was the highest per capita consumer of codeine, 
hydromorphone, morphine, and pethidine; the second highest per capita consumer of fentanyl 
and oxycodone; and the third highest per capita consumer of prescription narcotics in the world 
(International Narcotics Control Board, 2011). 
Opioid-Related Consequences 
 Opioids are the single largest contributor to illicit drug-related mortality and morbidity 
worldwide (Brown & Lawrence, 2009), and there are more deaths resulting from prescription 
opioid overdose than from heroin and cocaine combined (National Institute on Drug Abuse, 
2014). Untreated heroin dependence kills between 1 and 3% of users each year, and half of these 
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deaths are due to heroin overdose (Darke & Hall, 2003; Sporer, 1999). In a Toronto sample of 
untreated heroin users half reported at least one almost fatal overdose experience in their lifetime 
(Caplehorn & Drummer, 1999), and between 1994 and 2000, British Columbia was reporting 
one heroin-related overdose death per day (Fischer, Rehm, & Blitz-Miller, 2000). Regular heroin 
users have a mortality rate that is 13 times greater than the general population (Hulse, English, 
Milne, & Holman, 1999), and the risk of death among heroin users is 29% by age 40 and 53% by 
age 50 (Davoli et al., 1997). 
 Opioid use related morbidity is also quite serious. Morbidity refers to the increased 
incidence of disease due to opioid use and includes illnesses such as cardiac arrhythmia, 
respiratory depression, chronic liver disease, chronic renal disease, tuberculosis, human 
immunodeficiency virus (HIV) and other sexually transmitted diseases and infections, chronic 
pain, injuries, non-fatal overdoses, and comorbidity with other substance use disorders (Currie & 
Wild, 2012; Kreek, 1978; Veilleux, Colvin, Anderson, York, & Heinz, 2010). Also common 
among opioid dependent individuals are high comorbidity rates of non-substance related 
psychological disorders, particularly affective disorders (e.g., depression and anxiety), 
posttraumatic stress disorder, and antisocial personality disorder (Veilleux et al., 2010).  
 Chronic opioid use is linked with impairment on many dimensions of cognitive 
functioning (Gruber et al., 2006) including deficits in memory, learning, and attention (Davis, 
Liddiard, & McMillan, 2002; Grant, Adams, Carlin, & Rennick, 1977; World Health 
Organization, United Nations Office on Drugs and Crime, & UNAIDS, 2004). Findings in this 
area are relatively new and under examined, so it is uncertain whether these deficits are 
permanent or if they diminish once opioid use ceases (Davis et al., 2002). For example, Davis 
and colleagues (2002) found a higher occurrence of cognitive impairment on various Wechsler 
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Adult Intelligence Scale-Revised subtests in a group of individuals on methadone compared to 
past opioid users. Their results did not reach statistical significance, but suggested that if opioids 
do in fact cause cognitive impairment, some recovery in cognitive ability may occur during 
abstinence (Davis et al., 2002). Other studies conducted by Darke, Sims, McDonald, and Wickes 
(2000) and Ornstein and colleagues (2000) concluded that individuals using methadone or heroin 
show cognitive deficits that are irreversible; however, both of these studies used inappropriate 
control groups. Because of the difficulties in studying opioid users and the many aspects of 
cognitive impairment, current results are not conclusive (Davis et al., 2002). 
 Opioids are also considered one of the most harmful illicit drug classes due to the risks 
associated with the illegal market of opioids (United Nations Office on Drugs and Crime, 2014) 
and injection drug use (Karon, Fleming, Steketee, & De Cock, 2001). Users of illicit opioids 
often spend most of their time finding, buying, and taking the drug, which can create a vicious 
cycle of criminal pursuits (Amato et al., 2005). To obtain illicit opioids users often become 
involved in criminal activities such as theft, violence, or prostitution (in exchange for money or 
drugs), which have legal and health implications such as incarceration and an increased risk of 
contracting infectious diseases (Amato et al., 2005; Kreek & Vocci, 2002; Ward et al., 1999; 
Wood et al., 2005). Injection drug use is also associated with health compromising practices such 
as needle sharing, which is closely related to the spread of HIV (Karon et al., 2001). In North 
America one quarter of new HIV cases are due to injection drug use (Karon et al., 2001). 
Defining Opioid-Related Disorders 
 Opioid-related disorder, as outlined in the Diagnostic and Statistical Manual of Mental 
Disorders (5th edition; DSM-5), involves a problematic pattern of opioid use causing clinically 
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significant distress or impairment (American Psychiatric Association, 2013). This is determined 
by the presence of at least two of 11 circumstances/behaviours in the past 12 months, including  
• consumption of opioids in larger amounts or for longer periods of time than intended;  
• a persistent desire or unsuccessful efforts to control opioid use;  
• spending a great deal of time obtaining, using, or recovering from opioids or opioid use;  
• cravings for opioids; 
• failure to fulfill obligations at work, school, or home due to recurrent opioid use; 
• recurrent social or interpersonal problems caused or made worse by the effects of opioids;  
• giving up or reducing time spent on social, occupational, or recreational activities because of 
opioid use; 
• use of opioids in physically hazardous situations;  
• persistent or recurrent physical or psychological problems caused or made worse by the 
effects of opioids;  
• tolerance to the effects of opioids (either through the need to use more of the drug to achieve 
intoxication or a diminished effect when using the same amount of the drug); and 
• withdrawal from opioids (experiencing dysphoric mood, nausea, vomiting, muscle aches, 
lacrimation [watering eyes], rhinorrhea [runny nose], pupillary dilation, piloerection [goose 
bumps], sweating, diarrhea, yawning, fever, or insomnia when stopping opioid use, or taking 
closely related substances to avoid withdrawal symptoms; American Psychiatric Association, 
2013).  
Opioid-related disorders are also classified according to severity (mild, moderate, and severe) 
based on the number of symptoms present (American Psychiatric Association, 2013). Related 
diagnoses include opioid intoxication, opioid withdrawal, other opioid-induced disorders (i.e., 
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depressive, anxiety, sleep-wake, sexual, or neurocognitive disorders, which have been 
demonstrably induced by opioid consumption), and unspecified opioid-related disorder 
(American Psychiatric Association, 2013). 
 While the terms dependence and abuse are no longer included in the most recent edition 
of the Diagnostic and Statistical Manual of Mental Disorders (i.e., DSM-5; American 
Psychiatric Association, 2013) this language is used throughout literature published prior to the 
5th edition of the manual. In the fourth edition, text revision of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV-TR) dependence and abuse fall under the broader 
category of substance use disorders denoting that these disorders result from the act of using the 
substance, whereas the disorders of substance intoxication and withdrawal fall under the 
category of substance-induced disorders denoting that these disorders result from the effects of 
the substance itself (American Psychiatric Association, 2000). The DSM-IV-TR defines 
substance dependence as a troublesome pattern of substance use that leads to clinically 
significant distress or impairment (American Psychiatric Association, 2000). This is determined 
by the presence of at least three of seven circumstances/behaviours in the past 12 months, 
including 
• tolerance;  
• withdrawal;  
• consumption of a substance in larger amounts or for a longer period of time than intended;  
• a persistent desire or unsuccessful efforts to control substance use;  
• spending a great deal of time obtaining, using, or recovering from the substance;  
• giving up or reducing time spent on social, occupational, or recreational activities because of 
substance use; and 
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• persistent or recurrent physical or psychological problems caused or made worse by the 
effects of the substance (American Psychiatric Association, 2000). 
The DSM-IV-TR defines substance abuse as a troublesome pattern of substance use that leads to 
clinically significant distress or impairment (American Psychiatric Association, 2000). This is 
determined by the presence of at least one of four circumstances/behaviours in the past 12 
months, including 
• failure to fulfill obligations at work, school, or home due to recurrent substance use; 
• recurrent use of substances in physically hazardous situations;  
• recurrent legal problems related to substance use; and 
• recurrent social or interpersonal problems caused or made worse by the effects of a substance 
(American Psychiatric Association, 2000).  
The diagnostic criteria for substance dependence and abuse are now encompassed under the term 
opioid-related disorder; however, when the literature discusses substance dependence it is 
referring to the cognitive, behavioural, and physiological symptoms that demonstrate an 
individual continues to use the substance despite substance-related issues (American Psychiatric 
Association, 2000). When the literature discusses substance abuse it is referring to the 
problematic pattern of substance use as demonstrated by recurring adverse consequences related 
to the repeated use of the substance (American Psychiatric Association, 2000). 
 Given the relatively recent emergence of illicit prescription opioid use, data surrounding 
its abuse and dependence potential is not currently well understood (Ward, Hall, & Mattick, 
1999). There appears to be a genetic predisposition for opioid dependence with some family 
members sharing lower-than-average levels of endorphins (Drug Policy Alliance, 2006), which 
could contribute to an individual’s inclination to use opioids to self-medicate. However, genetics 
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are not the only factor contributing to opioid dependence; a genetics-environment interaction is a 
more realistic model (Conrod, Pihl, Stewart, & Dongier, 2000; Drug Policy Alliance, 2006; 
Khantzian, 1997).  
Definition of Cultural Terms 
 The use of the term First Nation comprises a diversity of populations, each possessing a 
unique expression of language, culture, and geographical influence (Kirmayer, Simpson, & 
Cargo, 2003; Romanow, 2002; Stephens, Nettleton, Porter, Willis, & Clark, 2005). The term 
First Nations is used in this document to describe members of Indigenous groups in Canada who 
are neither Inuit nor Métis (Milloy et al., 2010), while the broader term Aboriginal, refers to First 
Nations, Inuit (originating from the Arctic and sub-Arctic regions), and Métis (descendants of 
marriages between First Nations individuals and European settlers) populations (Constitution 
Act, 1982, s 35; Milloy et al., 2010; Policy Research Initiative, 2003). Approximately 4.3% of 
the Canadian population (1,400,685 people) reported Aboriginal identity in the 2011 Census, of 
which, 60.8% identify as First Nations, 32.3% identify as Métis, and 4.2% identify as Inuit 
(Statistics Canada, 2011). The term Indigenous refers to populations on an international scale 
and is used to delineate the first inhabitants of an area from European colonial settlers (I. 
Anderson et al., 2006; Montenegro & Stephens, 2006; Sylvain, 2002). First Nations populations 
are the focus of this study, with Aboriginal and Indigenous health being described to provide 
context, or when no other data is available. Where possible, specific group names are used. 
Opioid Use Among First Nations Peoples 
 First Nations populations experience many adverse consequences associated with opioid 
use; the most serious consequence experienced is mortality. Injury and poisoning are the leading 
causes of death among First Nations individuals in Canada, and the use of substances are a major 
EVALUATING AN ON-RESERVE MMT PROGRAM 13 
contributing factor (Jacobs & Gill, 2002). In Canada, First Nations identification is associated 
with a highly elevated burden of overdose mortality with First Nations individuals experiencing 
overdose mortality at up to 5 times the rate of non-First Nations individuals (Milloy et al., 2010). 
From 2001 to 2005, 13.3% of First Nations deaths were due to overdose mortality compared to 
4.8% of deaths in the general population (Milloy et al., 2010). Injection-related deaths 
specifically are also approximately 2 times as frequent among First Nations individuals (Milloy 
et al., 2010). National-level data for opioid-related deaths is not currently available, but data 
surrounding emergency room visits for opioid-related issues (e.g., withdrawal, overdose, and 
intoxication) are accessible; in 2010 there were 55 opioid-related emergency room visits by First 
Nations individuals for every 10,000 people in Ontario, compared to 3.7 visits per 10,000 for all 
of Ontarians (Canadian Centre on Substance Abuse, 2013). 
 The medical implications for Aboriginal opioid use also include HIV infection (Public 
Health Agency of Canada, 2012). While Aboriginal peoples account for less than 5% of the 
population in Canada, they currently represent about 8.9% of the total number of HIV infections 
and are becoming HIV positive 3.5 times more often than non-Aboriginal Canadians (Public 
Health Agency of Canada, 2012). Aboriginal individuals who use injection drugs are the fastest 
growing group of new HIV cases in Canada (Wardman & Quantz, 2006), and 58.1% of 
Aboriginal individuals with HIV were exposed through injection drug use (Public Health Agency 
of Canada, 2012).  
 The psychological difficulties experienced by Aboriginal individuals who use opioids 
differ from their non-opioid using counterparts. Aboriginal individuals who use opioids tend to 
experience higher rates of depression, have more trouble managing aggressive behaviour, and 
may be more bothered by the presence of a psychological difficulty than their non-using 
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counterparts (Jacobs & Gill, 2002). In relation to these psychological difficulties, Aboriginal 
individuals who abuse substances report being quite bothered by family issues and also have 
problems getting along with friends (Jacobs & Gill, 2002). These individuals are more likely to 
live with someone who is currently, or has in the past, abused drugs or alcohol as well (Jacobs & 
Gill, 2002). These psychological concerns have effects on health in relation to suicide, family 
disruption and violence, accidents, and legal problems (Jacobs & Gill, 2002).  
 When it comes to the risks associated with the illicit use and injection of opioids, 
Aboriginal populations experience higher levels of risk as well (Canadian Foundation for Drug 
Policy, 1998). Aboriginal populations experience higher rates of crime related to substance use; 
Aboriginal individuals currently represent 22% of the incarcerated population in Canada with 
many offenses relating to illicit drug use (Canadian Foundation for Drug Policy, 1998; Prison 
Justice, 2007). When considering injection related risks, HIV infected drug users are 
significantly more likely to report lending a used syringe if they had been incarcerated during the 
past 6 months (Wood et al., 2005). Because Aboriginal peoples are also incarcerated at a much 
higher rate than non-Aboriginal peoples (Canadian Foundation for Drug Policy, 1998; Prison 
Justice, 2007), these unsafe injection acts practiced in prison may represent an increased risk for 
Aboriginal individuals.  
 There are several commonly speculated reasons for why substance use is higher among 
First Nations peoples; the use of substances is a way to cope with and provide escape from 
challenging life situations and constant stressors (Health Canada, 2011). Some of these 
challenges come from a long history of colonization, which includes the criminalization of 
culture and language, rapid cultural change, the creation of the reserve system, the change from 
an active to a sedentary lifestyle, systematic racism, forced assimilation through residential 
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schools, and child-welfare policies (Health Canada, 2011; Reading & Wien, 2013). All of these 
factors affect the health and wellbeing of communities in many ways, contributing to lower 
social and economic status, poor nutrition, violence, crowded living conditions, and high rates of 
substance use and associated problems (Health Canada, 2011; Reading & Wien, 2013). Other 
authors have found similar vulnerabilities to drug use; Aboriginal individuals who live in poverty 
with low education, unstable family structure, frequent physical abuse, or poor social support 
networks, are at a high risk of substance abuse (Duran et al., 2005; Methadone Strategy Working 
Group, 2001).  
 Understanding the historical connection behind higher substance use rates among First 
Nations populations is vital to overcoming culturally specific treatment access barriers. Wing, 
Crow, and Thompson (1995) have identified two cultural barriers as obstacles to obtaining help 
with substance abuse for Aboriginal populations with traditional beliefs. First, an effective 
relationship between a therapist and an Aboriginal client may take more time to grow, as 
developing trust and intimacy with new people demands time and experience (Wing et al., 1995). 
The history of colonization for Aboriginal communities has made it difficult for some Aboriginal 
peoples to trust medical professionals of different cultural backgrounds (Wing et al., 1995). 
Second, for traditional Aboriginal peoples it can be shameful to admit having problems with 
substances, because they perceive their difficulties as resulting from having lost touch with the 
spiritual world; where it is believed that a spiritual person does not abuse substances, admitting 
substance abuse problems is synonymous with admitting loss of spirituality (Wing et al., 1995). 
Other cultural treatment barriers arise around the stigmatization, negative stereotypes, and lack 
of cultural awareness that Aboriginal peoples experience from service providers (Wardman & 
Quantz, 2006). 
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 When western health care is the only service available for a particular difficulty, access 
barriers remain for Aboriginal communities (Pal, Das, Sengupta, & Chaudhury, 2002; Simmons 
& Voyle, 2003; Wilkinson, Ryan, & Hiller, 2001). Access is constrained, not only by cultural 
barriers, but also by financial and geographic obstacles, especially in remote areas where 
services are challenging and expensive to provide (Palafox, Buenconsejo-Lum, Ka’ano’I, & 
Yamada, 2001). Many individuals in remote communities have low finances, few treatment 
choices, inconvenient treatment hours where treatment is available, and lack of transportation to 
treatment centres and hospitals (Chong & Herman-Stahl, 2003). All of these things represent 
serious barriers to treatment for First Nations populations. 
 These barriers to treatment in Aboriginal communities outline the necessity of the 
creation of culturally relevant treatment approaches. Culturally relevant treatment does not 
necessitate that treatment follow traditional practices, as First Nations communities differ when 
it comes to connection to traditional culture (Jiwa, Kelly, & St. Pierre-Hansen, 2008); when 
treatment as usual may be effective and/or desired in a First Nations community, these services 
are not easily accessible (Chong & Herman-Stahl, 2003). Where traditional practices are desired, 
however, this is essential for treatment success. The degree to which an Aboriginal person 
identifies with their culture, has been identified as a key protective factor associated with 
reduced rates of substance use, reduced rates of suicide, and improved mental health outcomes 
(Bals, Turi, Skre, & Kvernmo, 2011; Fleming & Ledogar, 2008; McIvor & Napoleon, 2009). 
Spiritual practices have been found to be a direct measure of protection against substance use 
problems as they often include cultural teachings that promote abstinence or only moderate use 
of psychoactive substances (Currie, Wild, Schopflocher, Laing, & Veugelers, 2013). Aboriginal 
elders and healers often believe that the connection to culture, community, and spirituality is 
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healing, and that it is the disconnection from these aspects that makes people unhealthy 
(McCormick, 2000). Health can be understood by some First Nations populations as a state of 
unity and balance across the biological, psychological, social, and spiritual aspects of life, rather 
than simply the absence of disease (Dell et al., 2012). This factor is necessary to consider when 
searching for effective treatments for substance-related disorders in First Nations populations 
with traditional views.  
Treatment for Opioid-Related Disorders 
 Opioids represent a serious clinical problem for drug treatment (Brown & Lawrence, 
2009). One challenge surrounding treatment for opioid use is that it is often difficult to motivate 
long-term, high-risk opioid users to enter drug treatment (Darke & Hall, 2003). One reason for 
this is that opioids are difficult to withdraw from as the somatic symptoms of withdrawal (e.g., 
severe insomnia, weakness, nausea, vomiting, diarrhea, chills, fever, and muscle spasms; Capital 
Health, 2005) last several days and the motivational and cognitive impairments last several 
months (McLellan, Lewis, O’Brien, & Kleber, 2000). The learned aspects of opioid tolerance 
may never return to normal (Wise & Bozarth, 1981). Related to this difficult withdrawal process, 
opioid dependent individuals rarely enter treatment on their own or with the plan to become 
abstinent (Hser, Anglin, & Powers, 1993); most dependent users enter treatment due to pressure 
from family or friends, or because of legal requirements (Gerstein & Harwood, 1990).   
 Only 5% of those who enter treatment have the intent to become totally abstinent from 
opioids (Hser et al., 1993), and many individuals who are opioid dependent consider treatment to 
be a transitional phase to help them through a certain period in their lives (Potik, Adelson, & 
Schreiber, 2007). Those who do attempt to become abstinent have little success (Hser, Hoffman, 
Grella, & Anglin, 2001; Termorshuizen, Krol, Prins, & van Ameijden, 2005). Longitudinal 
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studies have consistently found that most patients are unable to complete tapering off of opioids 
successfully and those who are able, relapse to opioid use within 1 year (Latowsky, 1996; 
Magura & Rosenblum, 2001; Milby, 1988). Understanding the patient’s perspective and 
expectations for treatment is another challenge; in order for the treatment to be effective, it must 
be tailored to the patient’s needs whether that means achieving abstinence or getting through a 
transitional phase (Beresford, 2007; Bridges & Jones, 2007; Oliver et al., 2001; Trujols et al., 
2011). 
 The persistent susceptibility to relapse among opioid users regardless of the time spent 
abstinent is another challenge surrounding the treatment of opioid dependence (Kalivas & 
Volkow, 2005; O’Brien, 1997). Historically, 60% of heroin users in treatment programs tend to 
relapse after 3 months, while 75 to 85% relapse after 12 months of treatment (Hunt, Barnett, & 
Branch, 1971). A more recent study of opioid dependent individuals found that after completing 
three years of treatment, 56% of individuals relapsed within 1 year (Tang, Zhao, Zhao, & 
Cubells, 2006). While the withdrawal process from opioids is quite difficult, maintaining 
abstinence is much more arduous, as demonstrated by the fact that relapse is so common (Amato 
et al., 2005; Gerstein & Harwood, 1990; Ward et al., 1999), making this challenge particularly 
crucial to consider when determining treatment options.  
 Because of the prevalence of relapse, most opioid dependence treatment strategies are 
aimed at preventing relapse rather than eliminating dependence altogether (Amato et al., 2005; 
Gerstein & Harwood, 1990; Ward et al., 1999). In the past, drug dependence has been treated as 
an acute illness, but with such high relapse rates commonly realized, long-term care strategies 
are being used to produce lasting benefits (McLellan et al., 2000). It is now understood that drug 
dependence should be evaluated and treated like other chronic illnesses and as a chronic 
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relapsing disorder (McLellan et al., 2000). Reasons for relapse include long-term depression, low 
energy, drug cravings, and sudden attacks of withdrawal sickness (Drug Policy Alliance, 2006); 
stress also represents a risk factor for opioid relapse (Sinha, Kimmerling, Doebrick, & Kosten, 
2007). For some these relapse triggers diminish over time, but for others they do not (Drug 
Policy Alliance, 2006). Regardless of how relapse is triggered it is not considered an issue of will 
power, but rather a result of cumulative neurochemical changes to the brain (Brown & Lawrence, 
2009; Drug Policy Alliance, 2006; Gossop, Green, Phillips, & Bradley, 1989).  
 There are several different approaches to treating opioid-related disorders including 
detoxification and relapse prevention treatment programs, therapeutic communities, outpatient 
drug-free counseling, and long-term opioid substitution (Amato et al., 2005). Detoxification is 
often considered the first step in the treatment of opioid dependence when the primary goal is 
abstinence (Gerstein & Harwood, 1990; Ward et al., 1999), but consistently, the most effective 
treatment for opioid dependence is long-term opioid substitution (J. F. Anderson, 1999; National 
Institutes of Health, 1999). This consists of substituting a safer substance (e.g., methadone) for 
the substance being abused to help the user gain control over their opioid use (Ward et al., 1999).  
 During long-term maintenance treatment an individual is physically dependent on the 
maintenance medication, however, once the dose of the new substance is stabilized, intoxication 
and withdrawal occur infrequently (Ward et al., 1999). This leads to less time being spent on 
drug-related activities and life returning to a more regular state (Ward et al., 1999). This type of 
treatment helps to increase the time between relapses and reduces the intensity, frequency, and 
length of relapses if they do occur (Leshner, 1998). Enrollment in long-term maintenance 
treatment also substantially reduces the risk of fatal and nonfatal overdose from opioids 
(Caplehorn, Dalton, Cluff, & Petrenas, 1994; Stewart, Gossop, & Marsden, 2002), criminal 
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activity, and HIV seroconversion, and promotes psychosocial adjustment (Farrell et al., 1994; 
Leshner, 1998; Ward et al., 1999). Long-term maintenance treatments are known as harm 
reduction programs as they attempt to reduce risky behaviour rather than achieve total abstinence 
(Rogers & Ruefli, 2004). 
 Methadone maintenance therapy. Methadone is a full opioid agonist at the µ receptor 
and has a slow onset and a long half-life, which makes it useful for alleviating the symptoms of 
opioid withdrawal and also decreasing the chronic craving for opioids (Capital Health, 2005; 
McLellan et al., 2000). It is administered orally in the form of a tablet, powder, or liquid syrup, 
and reduces the euphoric effects of other opioids, which makes it particularly helpful in 
treatment (Capital Health, 2005; Drug Policy Alliance, 2006; Tetrault & Fiellin, 2012). Peak 
plasma concentration is reached 2 to 4 hours after methadone is orally administered, and when 
methadone is taken once a day, withdrawal symptoms are eliminated for 24 to 36 hours 
(Faggiano, Vigna-Taglianti, Versino, & Lemma, 2008; Koob, 1992). Tolerance to methadone 
develops very slowly, if at all, so individuals can be maintained on the same dose of methadone 
for many years (Capital Health, 2005; Curran, Kleckham, Bearn, Strang, & Wanigaratne, 2001). 
 Methadone was developed in Germany to be used as a substitute for morphine during 
World War II (Capital Health, 2005), but has been in use for the treatment of opioid dependence 
since 1963 (Fullerton et al., 2014; Veilleux et al., 2010). Methadone is used in long-term 
maintenance therapy where an individual is maintained on methadone for an indefinite period of 
time (Capital Health, 2005). In this type of treatment program methadone is dispensed daily at a 
treatment facility to minimize risks of diversion, but after a period of time of appropriate clinic 
attendance (usually 3 months), the absence of behavioural problems at the clinic, lack of known 
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criminal activity, and evidence of a stable home with a place to store methadone safely, 
individuals may be eligible for take-home doses, also known as “carries” (Fullerton et al., 2014).  
 To prescribe methadone in Canada, physicians are required to obtain an exemption from 
the Controlled Drugs and Substances Act by taking a 1-day course and a 2-day practicum in a 
methadone maintenance therapy practice (Strike, Urbanoski, Fischer, Marsh, & Millson, 2005). 
Methadone maintenance physicians were once restricted to having 20 patients on methadone at 
one time, but this restriction was lifted in 1996, which increased the number of individuals able 
to receive treatment (Strike, Urbanoski, et al., 2005). In 1996, 46% of methadone maintenance 
therapy prescribing physicians had 21 patients or more; in 2001, 56% of physicians had more 
than 21 patients with a median caseload of 29 patients (ranging between one and 426 patients; 
Strike, Urbanoski, et al., 2005). In Ontario in 2011, there were 29,442 active methadone 
maintenance therapy clients (Doukas, 2011). 
 Methadone maintenance therapy is the primary and most effective treatment for opioid 
dependence in Canada (J. F. Anderson, 1999; National Institutes of Health, 1999), and the goal 
of maintenance treatment is to reduce or eliminate illicit opioid use, which can in turn have 
several other positive outcomes (Fullerton et al., 2014). Positive outcomes of methadone 
maintenance therapy include  
• reduced criminal activity (Ball, Lange, Myers, & Friedman, 1998; Dole & Nyswander, 1965; 
Fullerton et al., 2014; Joseph, Stancliff, & Langrod, 2000; Judson, Ortiz, Crouse, Carney, & 
Goldstein, 1980; McLellan et al., 2000; Simpson, Joe, & Bracy, 1982; Ward et al., 1999); 
• reduced risks associated with injection drug use (e.g., reduction in shared needles; Ball et al., 
1998; Capital Health, 2005; Chatham, Hiller, Rowan-Szal, Joe, & Simpson, 1999; Dolan et 
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al., 2003; Metzger et al., 1993; Simpson et al., 1982; Stark, Muller, Bienzle, & Guggenmoos-
Holzmann, 1996); 
• reduced spread of infectious diseases (e.g., HIV and hepatitis C; Abbott, Weller, Delaney, & 
Moore; 1998; Avants et al., 1999; Ball et al., 1998; Fullerton et al., 2014; Gibson, Flynn, & 
McCarthy, 1999; Joseph et al., 2000; McLellan et al., 2000; Simpson et al., 1982; Ward et 
al., 1999);  
• decreases in multiple sex partners or exchanges of sex for drugs (Camacho, Bartholomew, 
Joe, Cloud, & Simpson, 1996; Chatham et al., 1999; Grella, Anglin, Rawson, Crowley, & 
Hasson, 1996);  
• reduced mortality (Caplehorn et al., 1994; Fullerton et al., 2014; Joseph et al., 2000);  
• less substance use in general (Capital Health, 2005; Dole & Nyswander, 1965); and 
• improved life functioning (Capital Health, 2005; Dole & Nyswander, 1965; Judson et al., 
1980; Simpson et al., 1982; Ward et al., 1999). 
 Capital Health (2005) found that 95.5% of participants reported decreased participation in 
high-risk behaviours since their admission into a methadone maintenance program. Over 84% of 
participants reported improved housing conditions, 61.4% reported improved employment status, 
84.1% reported a decrease in criminal activity involvement, 80% reported abstaining from using 
alcohol and other drugs, and 81.2% reported an increase in family support since admission to a 
methadone maintenance program (Capital Health, 2005). Opioid users entering treatment 
frequently report a low quality of life, but the first months of treatment lead to a significant 
increase in many areas of life quality (e.g., health, employment status, and relationship status; De 
Maeyer et al., 2011).  
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 Five dominant themes emerge when methadone clients discuss quality of life including 
the status of social relationships, psychological wellbeing, occupation status, independence, and 
having a meaningful life (De Maeyer et al., 2011). After spending time in treatment, individuals’ 
overall health improves, although this depends largely on the time dependent on opioids, the 
reason for entering treatment, and the length of treatment (Dole & Joseph, 1978; Joseph et al., 
2000). Another positive outcome of methadone treatment is that when appropriately prescribed, 
methadone normalizes the physiological functions that have been damaged by opioid use such as 
stress responses of the central nervous system and the ability to experience normal emotions as 
well as acute and chronic pain (Joseph et al., 2000). 
 No differences have been found in the rates of long-term abstinence between individuals 
who enter methadone maintenance treatment and drug-free residential treatment (Maddux & 
Desmond, 1992), which suggests that methadone maintenance therapy does not extend opioid 
dependence in any way. This is particularly important as longer times spent in treatment are 
more effective, and the best results from opioid dependence treatments have been observed in 
individuals in long-term methadone maintenance therapy (McLellan et al., 2000). The longer an 
individual stays in methadone treatment, the better chance they have of stopping the abuse of 
opioids and other substances (Health Canada, 2002; Zanis & Woody, 1998). More time spent in 
methadone treatment also lowers an individual’s risk of death (Health Canada, 2002; Zanis & 
Woody, 1998).  
 Methadone maintenance therapy has been particularly effective and reduces crime costs 
for individuals who are in treatment for at least 1 year (Flynn, Porto, Rounds-Bryant, & 
Kristiansen, 2003; Simpson, Joe, & Brown, 1997). Additionally, individuals who remain in 
methadone treatment for 1, 2, or 3 years or more, also tend to do better in all areas, including the 
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reduction or elimination of illicit opioid use and other illicit substances, improvement in health 
status, improved socialization, increased employment, the ability to receive higher education, 
and decreased criminality (Kreek & Vocci, 2002). There are also 6% fewer deaths among those 
in methadone maintenance therapy compared to those who have been discharged (Woody, Kane, 
Lewis, & Thompson, 2007).  
 Short-term methadone detoxification treatment of approximately 21 days has been tested 
as an alternative to methadone maintenance therapy, but has poor retention and high relapse rates 
(Mann & Feit, 1982; Sorensen, Hargreaves, & Weinberg, 1982). In fact, it is recommended that 
individuals remain in methadone maintenance therapy indefinitely due to extreme difficulty with 
tapering off methadone (Calsyn, Malcy, & Saxon, 2006). Methadone maintenance therapy is 
consistently found to be superior to other treatments in retaining individuals in treatment (Amato 
et al., 2005; Gossop, Marsden, Stewart, & Treacy, 2001). When comparing retention of 
individuals on a placebo to individuals on methadone, placebo groups show a 10% retention rate 
after 32 weeks, while methadone groups show a 76% retention rate (Newman & Whitehill, 
1978). More recently, it was found that 50% of methadone patients remain in treatment for 730 
days or longer, and retention rates differ by region so that in areas with fewer methadone 
prescribing physicians, retention rates are higher; it is suspected that a shortage of prescribers 
may dissuade dropout (Strike, Gnam, et al., 2005). 
 The dose of methadone prescribed also affects retention in long-term maintenance 
therapy (Amato et al., 2005; Fullerton et al., 2014). Methadone is a dose dependent substance, 
meaning that higher doses are more effective than lower doses in retaining patients, reducing the 
use of other substances, and reducing symptoms of withdrawal (Amato et al., 2005; Connock et 
al., 2007; Fletcher & Battjes, 1999; Fullerton et al., 2014; Mattick, Breen, Kimber, & Davoli, 
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2009; Veilleux et al., 2010). When different doses are compared, higher doses are more effective 
than medium and low doses, and methadone maintenance therapy effectiveness increases when 
methadone is prescribed at doses of 60-mg or more (Amato et al., 2005; Fullerton et al., 2014). 
 While length of time in treatment and dose are required considerations, in order for 
methadone maintenance therapy to be effective, it is necessary that other services be offered with 
the methadone prescription (National Institutes of Health, 1999). The addition of social, medical, 
and psychological services to methadone maintenance therapy has the highest probability of 
being effective (McLellan, Arndt, Metzger, Woody, & O’Brien, 1993; National Institutes of 
Health, 1999). Even very brief motivational support and counseling can have an effect on 
recovery from opioid dependence (Plater-Zyberk, Varenbut, Daiter, & Worster, 2012).  
 Another key aspect to the effectiveness of methadone maintenance therapy is considering 
the clients’ perspectives. Those who believe their opinions influence their methadone dose a 
great deal are more satisfied with their treatment overall (Pérez de los Cobos, Trujols, 
Valderrama, Valero, & Puig, 2005). Also, the better patients feel about methadone as a 
medication for opioid dependence, the more satisfaction they find with their methadone 
maintenance therapy (Pérez de los Cobos et al., 2005).  
 While methadone maintenance therapy is consistently shown to be the most effective 
treatment for opioid-related disorders, there are some concerns related to taking methadone in 
general and long-term. The side effects of methadone include backaches, constipation, sweating, 
body aches, weight gain, headaches, nausea, sleepiness, loss of sex-drive, numbness, and 
seizures (Fischer, Chin, Kuo, Kirst, & Vlahov, 2002). Aside from these side effects, there are 
also concerns about possible cognitive effects of acute and long-term methadone use, but little 
research has investigated this (Gruber et al., 2006). Some aspects of neurocognitive functioning 
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such as attention, appear to be unaffected by long-term methadone maintenance, but other areas, 
such as learning and memory, may be more affected by long-term methadone use (Gruber et al., 
2006). One study found that when giving participants their full dose of methadone, delayed recall 
of prose was impaired (Curran et al., 2001), and another study found that methadone patients 
performed worse on measures of verbal fluency than drug free controls (Gruber et al., 2006). 
Methadone maintenance patients have, however, been found to improve in verbal and 
visuospatial encoding, recall, and psychomotor speed after 2 months in treatment, which 
suggests that the impairments found before treatment begins may actually be reversible with 
methadone treatment (Gruber et al., 2006). 
 The initial phases of methadone administration must be carefully monitored in order to 
prevent overdose, therefore daily dispense and supervised ingestion of methadone are utilized 
(Joseph et al., 2000; Neeleman & Farrell, 1997; Ward et al., 1999). Another serious concern is 
the possibility of household members, such as children, accidentally ingesting methadone when 
individuals are permitted to have their medication at home (Smialek, Monforte, Aronow, & 
Spitz, 1977; Ward et al., 1999). There is also the risk of an individual ingesting more than their 
prescribed dose or diverting their methadone to people who are not patients (Ward et al., 1999). 
There are stringent controls in place to minimize these dangerous possibilities, such as ensuring a 
good drug-response and practitioner-client relationship before allowing take-home doses, 
properly educating clients of the dangers of their medications, providing childproof containers 
and lockboxes, and obtaining regular urine screens (Peles, Schreiber, Sason, & Adelson, 2011; 
Ward et al., 1999). 
 Another issue to consider is the long-term risk of mortality associated with methadone 
use. Between 1999 and 2004, deaths attributed to methadone were reported to increase by 390%, 
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but evidence has found that this change was primarily due to increased prescriptions for 
methadone for pain rather than for methadone maintenance (Webster et al., 2011). The death rate 
from methadone prescriptions could also have increased due to the high rate of co-prescription of 
other opioids to those in methadone maintenance therapy. For example, a 7 year study found that 
over 18% of patients treated with methadone had been prescribed at least one prescription for a 
non-methadone opioid (Kurdyak et al., 2011). There are guidelines in place that specify drug 
monitoring during methadone maintenance through urine screening, which assists in limiting the 
possibility for clients to take an opioid prescription during their methadone maintenance 
treatment (Kurdyak et al., 2011). While there are concerns related to methadone use, medical 
studies have consistently shown that methadone maintenance is medically safe and nontoxic 
(Joseph et al., 2000). The benefits of methadone maintenance therapy outweigh the risks; in fact, 
the risk of mortality due to illicit opioid overdose or suicide among those untreated is much 
greater (Neeleman & Farrell, 1997).  
 Aside from the obstacles experienced uniquely by First Nations populations, other 
common barriers to entering methadone maintenance treatment exist. There appear to be 
misperceptions about methadone held by some opiate users; for example, it is believed that 
because methadone is synthetic and manmade, its side effects are worse, while heroin is organic 
and natural and therefore less harmful to use (Fischer et al., 2002). Along with this is the feeling 
that withdrawal from methadone is much worse than withdrawal from heroin (Fischer et al., 
2002). Many individuals also explain that because there is no high associated with methadone, 
the boredom is astronomical (Fischer et al., 2002).  
 Others choose not to enter methadone maintenance treatment because they believe that 
the structure of the treatment is too disciplinary, controlling, regimented, and disempowering, 
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which ultimately demands too much for too little benefit (Fischer et al., 2002). Individuals often 
want more choice and freedom in their course of treatment than they believe methadone 
maintenance therapy can offer (Fischer et al., 2002). Convenience of dispensing that allows for 
efficient use of time (e.g., seeing a counselor during the same visit) has also been listed as a 
noteworthy factor, as well as good relationships with the staff that dispense the medication 
(Anstice, Strike, & Brands, 2009). Where negative interactions with dispensing staff were 
reported, the complaints tended to focus on discriminatory feelings; clients felt that a program 
dispensary was more pleasant to deal with and less stigmatizing than having to visit a pharmacy 
(Anstice et al., 2009). The only trouble noted with using a program dispensary was the 
possibility of running into former friends who could be potential drug using triggers (Anstice et 
al., 2009). This was not as important an issue to individuals as the stigma associated with 
methadone use, as stigma and discrimination appear to be the most powerful forces preventing 
people from entering methadone treatment (Joseph et al., 2000; National Institutes of Health, 
1999). 
 The Matrix Model of Intensive Outpatient Alcohol and Drug Treatment. Methadone 
maintenance programs are most effective when coordinated with other services (De Maeyer et 
al., 2011; Ruefli & Rogers, 2004). Since substance abuse is most often interconnected with other 
health, social, economic, family, and mental health problems, a multidisciplinary approach is 
required (Miller & Miller, 2009). Additionally, because of the holistic conceptualization of 
health espoused by Aboriginal culture, multiple approaches to addressing health problems, often 
a combination of traditional and western medicine, is required (Stephens et al., 2005). 
Furthermore, given the prevalence of relapse among patients, extensive supports, services, and 
planning are necessary (Magura & Rosenblum, 2001; Veilleux et al., 2009).   
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 The ultimate goal of substance use health care is not just to address dependence, but also 
to enhance the quality of life of individuals who use substances and reduce the severity of 
problems associated with use (Joseph et al., 2000; Ruefli & Rogers, 2004); thus, there is value in 
incorporating practical, social, and environmental supports alongside methadone therapy (De 
Maeyer et al., 2011; Ruefli & Rogers, 2004). Methadone maintenance therapy programs 
typically consist of a variety of components including assessment, induction, methadone dosage, 
continual monitoring of illicit drug use, and counseling (Ward et al., 1999), but this cannot be 
accomplished by methadone maintenance therapy alone (De Maeyer et al., 2011). 
 The Matrix Model of Intensive Outpatient Alcohol and Drug Treatment is a program that 
addresses some of the additional needs of methadone maintenance therapy by combining 
multiple evidence-based practices such as cognitive-behavioural strategies, relapse prevention, 
motivational interviewing strategies, psychoeducation, and 12-step program involvement into an 
outpatient program (Rawson & McCann, 1995). The traditional Matrix program is 16 weeks, 
with structured group sessions and some individual sessions, and individuals are required to 
undergo weekly urine testing and are also highly encouraged to attend weekly support groups, as 
this group cohesion and support is instrumental in ensuring continued program adherence 
(Rawson & McCann, 2005). The program is guided by the principles of building a positive and 
collaborative relationship with the individual, creating structure and expectations, positively 
reinforcing behaviour change, and educating family regarding the expected course of recovery so 
that they may serve as supports (Jackson, Dykeman, Gahagan, Karabanow, & Parker, 2011; 
Rawson & McCann, 2005). The Matrix program has shown significantly higher retention, 
completion, and drug-free samples per week when compared to other usual treatments (Rawson 
& McCann, 2005).   
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Methadone Maintenance Therapy for First Nations Populations 
 Methadone is the best treatment for the general population, but there are unique 
challenges of treating opioid dependence with methadone maintenance therapy among First 
Nations populations. Aboriginal individuals who use injection drugs are less likely and slower to 
initiate methadone maintenance therapy compared to non-Aboriginal individuals (Wood et al., 
2007). Aboriginal identity has been consistently negatively associated with methadone 
maintenance therapy (Kerr, Marsh, Li, Montaner, & Wood, 2005) and it is likely that Aboriginal 
individuals initiate this type of treatment less often because of treatment access issues (i.e., 
financial, geographic, and cultural barriers; Chong & Herman-Stahl, 2003).  
 There are also challenges for First Nations individuals who are able to access treatment; 
the current model for alcohol and substance abuse treatment in remote Aboriginal communities 
involves referral to residential treatment centres for 3 to 6 weeks (Chong & Herman-Stahl, 2003; 
Wiebe & Huebert, 1996), which is challenging for many reasons. When individuals from remote 
communities are able to attend treatment centres, they are often unable to remain on the 
maintenance medication they were prescribed because of difficulties getting the medication 
when they return home (Chong & Herman-Stahl, 2003). Methadone maintenance therapy 
requires medical supervision, which makes it unavailable in communities without resident 
physicians; therefore, individuals who wish to receive treatment have to move to areas where 
methadone programs are available (Webster, 2013). This causes long-term changes for 
individuals in treatment, as methadone maintenance therapy is often a lifelong commitment 
(Methadone Strategy Working Group, 2013). When individuals wish to remain in their 
communities, they will attempt to remain abstinent when they return home, which is quite 
difficult because of the widespread use of substances in home communities (Chong & Herman-
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Stahl, 2003). With these stressors and little or no aftercare, relapse rates among Aboriginal 
populations are 35 to 85% and relapse most often occurs within 90 days (Chong & Herman-
Stahl, 2003; Wiebe & Huebert, 1996). These issues are serious and when the cultural importance 
of treatment is considered, it is understood that changes must be made and these problems must 
be resolved.  
 The keys to revitalizing communities and reducing alcohol and substance abuse are in 
providing effective healing programs and reclaiming cultural identity (Health Canada, 2011). 
Programs are being set in place to address substance abuse, particularly prescription drug abuse, 
in Aboriginal communities including multi-sectoral collaboration, research and surveillance, 
demand reduction, supply reduction, and treatment (Health Canada, 2011). Honouring Our 
Strengths, a combined publication from Health Canada, the National Native Alcohol and Drug 
Abuse Program, and the Assembly of First Nations, has a goal of matching people affected by 
substance use issues to the appropriate services and supports they need at the specific time in 
their journey (Health Canada, 2011). Honouring Our Strengths aims to coordinate among sectors 
to provide effective, client-centered, and also culturally safe services and supports (Health 
Canada, 2011). Many First Nations communities wish to achieve a balance between the mental, 
physical, emotional, and spiritual aspects of life, and culture is often vital in achieving this 
balance (Health Canada, 2011). However, each First Nations community is unique; the problems 
of substance use and the levels of aspiration towards traditional culture differ, and accordingly, 
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Cree Nations Treatment Haven 
 Cree Nations Treatment Haven is the first methadone maintenance therapy program to be 
offered in a First Nations community in Canada and is located in Ahtahkakoop Cree Nation, in 
Canwood, Saskatchewan. Ahtahkakoop Cree Nation has a population of 1,101 (Statistics 
Canada, 2006) and is located 72 kilometers northwest of Prince Albert and 165 kilometers south 
of Saskatoon. Established in 1986 as a fully accredited addiction service centre, Cree Nations 
Treatment Haven is a 20-bed facility that runs a 5-week inpatient program, a 16-week outpatient 
Matrix program, and other culturally relevant programs to assist in the full recovery of clients 
(e.g., sweats, church services, and group therapy; Ahenakew, 2012; Andkhoie, 2012). 
 The centre targets four partnering bands (Ahtahkakoop Cree Nation, Pelican Lake, 
Witchekan Lake, and Big River), but has clients from several other First Nations communities 
and clients do not have to be First Nations or a resident of the four bands to access services 
(Andkhoie, 2012). The centre has partnerships with First Nations and Inuit Health, provincial 
and regional health authorities, and the College of Physicians and Pharmacists to ensure that 
while services are culturally appropriate, quality is not compromised (Andkhoie, 2012). The 
services offered at Cree Nations Treatment Haven aim to balance each component of the First 
Nations medicine wheel (physical, emotional, mental, and spiritual wellbeing) with the inclusion 
of traditional sweats, smudging, drumming, and art, among other cultural activities (Andkhoie, 
2012). 
 Cree Nations Treatment Haven’s methadone maintenance treatment program began in 
January 2011 and was developed with the help of the community and through evidence-based 
approaches demonstrating the importance of culturally appropriate treatment (Andkhoie, 2012). 
In Saskatchewan, there are 2,136 individuals receiving methadone maintenance therapy and 30 
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prescribing physicians for all addictions (Luce & Strike, 2011). There are three provincially 
funded methadone maintenance clinics, with Cree Nations Treatment Haven being the first to be 
funded federally (Andkhoie, 2012). 
 Cree Nations Treatment Haven’s Matrix program. Cree Nations Treatment Haven has 
taken the evidence-based Matrix model and adapted it to best fit the culture, values, and needs of 
its clients (Ahenakew, 2012). The program is more compressed than the original model, running 
daily for 6 weeks, but maintains the same number of overall sessions (Ahenakew, 2012). This 
new schedule was adopted at the request of clients in order to facilitate full immersion in the 
program and permit the provision of additional programming throughout the day (Ahenakew, 
2012). As well, from the perspective of Cree Nations Treatment Haven, the prior schedule 
imposed a longer delay for clients requesting to re-enter the treatment program after having left 
for any reason (Ahenakew, 2012). Through group sessions, the clients progress from developing 
early recovery skills (10 sessions), to relapse prevention (13 sessions), then to family education 
(15 sessions), culminating with a final follow-up and graduation (two sessions; Ahenakew, 
2012).  
 Past program evaluation. In 2012, a detailed report of the first 15 months of operation 
was created of the 53 opioid-dependent clients at Cree Nations Treatment Haven where valuable 
demographic data was gained about the burden of disease that this First Nations population 
experiences (Andkhoie, 2012). While 53 clients went through the program, 82 requests were 
received and 29 clients were waitlisted (Andkhoie, 2012). These numbers indicate a definite 
interest and need for services among the surrounding communities.  
 Out of this evaluation it was found that more females than males were seeking methadone 
maintenance therapy (57.9% vs. 42.1%), which revealed that the program was overcoming 
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barriers usually faced by women that prevent them from seeking necessary assistance (Andkhoie, 
2012; Health Canada, 2011). Most clients were between the ages of 30 and 39 (57.9%), most 
were Cree (81.6%), and most had a spiritual belief system (60.5%), which emphasized the 
importance of culturally appropriate programming (Andkhoie, 2012). Most clients were 
unemployed (73.7%) and/or receiving welfare support upon entering treatment (86.8%; 
Andkhoie, 2012). The unemployment rate for clients at Cree Nations Treatment Haven was 
much higher than for adults in northern Saskatchewan First Nations communities (47.2%; First 
Nations Information Governance Centre, 2011), however, this is consistent with the fact that 
social and income factors are associated with substance use problems (Ahnquist, Wamala, & 
Lindstrom, 2012). Most clients also had a history of psychological problems (81.6%; Andkhoie, 
2012), which further underscores the importance of treatment. 
 The methadone maintenance therapy program was found to drastically decrease opioid 
use among clients (82% terminated use; Andkhoie, 2012). Upon completion of the evaluation, 
most clients used at least one less opioid, one less stimulant, and 1.5 less depressants than they 
were using before beginning treatment (Andkhoie, 2012). Clients were treated for non-opioid 
substance dependence prior to entering the program, so clients should not have been using any 
substances throughout the methadone maintenance program (Andkhoie, 2012). Also, few clients 
(5.3%) were involved in any form of illegal activity during a 30-day follow-up period 
(Andkhoie, 2012). Overall, the results of this evaluation were positive, but limited, and further 
evaluation was requested. 
The Current Study 
 This study contributed to the on-going evaluation of Cree Nations Treatment Haven’s 
methadone maintenance therapy program. 
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1. It was hypothesized that individuals in the methadone maintenance therapy program at Cree 
Nations Treatment Haven with higher rated improvement would report greater motivation for 
treatment and engagement in treatment. 
2. Individuals with higher rated improvement would report greater life quality, psychological 
functioning, physical health, and relationships with family and friends, and less 
psychological distress, problems with alcohol, criminality, employment and life difficulties, 
and overall risk. 
3. Individuals with higher rated improvement would report a more positive opinion of services. 
4. Individuals with a more positive opinion of services would report higher motivation and 
engagement. 
5. Individuals would report a decrease in drug use, high-risk, and criminal behaviours, and 




 Participants in this evaluation consisted of 30 clients in the methadone maintenance 
therapy program at Cree Nations Treatment Haven. Clients ranged in age from 23 to 55, with a 
mean age of 41 (SD = 8.18). Most of the clients were male (n = 16; 53.3%), and 93.3% (n = 28) 
identified as First Nations, with 70% (n = 21) also identifying as Cree. The majority of clients 
were single (n = 13; 43.3%) or cohabiting (n = 8; 26.7%), and lived alone in their own dwelling 
(n = 15; 50%) or with family or relatives (n = 8; 26.7%). The majority completed some high 
school (n = 11; 36.7%) or some post-secondary school (n = 7; 23.3%). 
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Procedures 
 Clients at Cree Nations Treatment Haven were informed of the details of this project by 
the staff at the centre. Clients who were currently receiving methadone maintenance therapy 
answered questions regarding their experiences during treatment through a series of 
questionnaires related to demographic information, quality of life, psychological functioning, 
health, social functioning, alcohol use, criminal involvement, motivation and engagement, level 
of risk, satisfaction with services, and impression of improvement. These clients were at various 
stages in treatment, but were asked to report when their treatment began. The majority of clients 
were unsure of their treatment start date (n = 8; 26.7%). Two clients (6.7%) began treatment in 
2015, six (20%) began in 2014, five (16.7%) began in 2013, one (3.3%) began in 2012, four 
(13.3%) began in 2011, and four (13.3%) began prior to 20101. The questionnaires completed 
were of the paper-and-pencil format and were completed on average, within 60 to 90 minutes. 
Upon completion, clients returned their questionnaires to the treatment centre staff who 
debriefed them and provided them with resources if they required mental health services. All 
questionnaires were de-identified by Cree Nations Treatment Haven staff to ensure anonymity of 
the clients to the evaluators. 
Measures  
 Demographic information. A demographic questionnaire was created to obtain 
information regarding age, sex, ethnicity, relationship status, level of education, and living 
situation. The demographics questionnaire also included questions asking the date of treatment 
entry, and whether they were part of the Matrix program. If they were in the Matrix program, 
they were asked to include the date they enrolled in and completed the program as well.  
                                                            
1 Cree Nations Treatment Haven began its methadone maintenance therapy program in January 
2011; however, it is possible and likely that these clients began methadone treatment elsewhere 
prior to Cree Nations Treatment Haven’s methadone maintenance therapy program development. 
EVALUATING AN ON-RESERVE MMT PROGRAM 37 
 Life Situation Survey (LSS; Chubon, 1999). This is a 20-item self-report questionnaire 
that asks clients about their current life situation. Items are scored on a 7-point scale with 
response options ranging from 1 (Agree Very Strongly) to 7 (Disagree Very Strongly). 
Statements on this scale include things like “My income is a constant source of worry” and “I 
like myself the way I am.” The reliability and validity of this measure have been supported by 
many studies and the internal consistency of the rating scale items are at acceptable levels with 
diverse populations (Chubon, 1999). It also shows good discriminant validity and is sensitive to 
both health and non-health factors affecting quality of life (Chubon, 1999). 
 User Generated Outcomes (UGO; Ruefli & Rogers, 2004). This is a 10-item self-
report questionnaire that asks clients about their current situation compared to their situation at 
treatment entry. Items are rated on a scale from Better to Worse by placing a mark on a line for 
where their current situation falls. For example, under “Places to live” there are statements given 
from, “House you rent or own” representing the best situation to “Sleeping in 
tunnels/roof/parks/stairways” representing the worst situation. Ruefli and Rogers (2004) 
recommend utilizing client-driven assessments such as this, rather than clinician-driven 
assessments. In an effort to develop an evaluation of health services that is based on desirable 
outcomes as identified by clients themselves, 240 clients in a harm reduction program were 
interviewed, and the items on this measure emerged as indicators of self-sufficiency and dignity 
(Ruefli & Rogers, 2004). The measure was validated with a second group of clients who reported 
the same indicators (Ruefli & Rogers, 2004).  
 TCU Client Evaluation of Psychological Functioning (PSY; Garner et al., 2007; Joe 
et al., 2002). This is a 33-item self-report questionnaire that asks clients about their 
psychological functioning over the past month. Items are scored on a 5-point scale with response 
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options ranging from 1 (Disagree Strongly) to 5 (Agree Strongly). Questions on this scale 
include things like “You feel interested in life” and “You feel hopeless about the future.” This 
scale is broken down into five subscales including self-esteem, depression, anxiety, decision-
making, and expectancy. This measure has good internal consistency (Simpson et al., 2012) and 
is reliable for use in treatment programs (Joe et al., 2002).  
 TCU Physical and Mental Health Status Screen (HLTH; Joe et al., 2004). This is a 
21-item self-report questionnaire that asks clients about physical and mental health issues over 
the past month. The first question asks “How many times in the past month have you gone to a 
hospital or clinic or seen a doctor or nurse for health problems?” with response options of 0 
(None), 1 (1 time), 2 (2-3 times), 3 (4-10 times), or 4 (over 10 times). The next 10 questions ask 
about problems and diseases experienced in the past month, such as “Stomach problems or 
ulcers” and “Skin disease or skin problems” and these items are rated on a 5-point scale with 
response options ranging from 0 (None of the time) to 5 (All of the time). These 11 questions 
make up the physical health subscale. The last 10 questions ask how often in the past month 
feelings such as being nervous or depressed were felt, and these items are rated on the same 5-
point scale mentioned above. These questions make up the psychological distress subscale. This 
measure has high levels of reliability and validity in groups of injection drug users (Hides et al., 
2007). 
 TCU Family and Friends Assessment (FMFR; Joe et al., 2004). This is a 21-item self-
report questionnaire that asks clients about their relationships with family and friends in the past 
month. Items are scored on a 5-point scale with response options ranging from 1 (Disagree 
Strongly) to 5 (Agree Strongly). Statements on this scale include things like “Your family got 
along well together” and “Your friends usually worked regularly on a job.” This scale is broken 
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into four subscales including family relationships, family drug use, peer socialization, and peer 
criminality. This measure has good reliability and validity (Joe et al., 2004). 
 TCU Alcohol Use and Problem Symptoms (ALC; Joe et al., 2004). This is a 15-item 
self-report questionnaire that asks clients about their alcohol use and problem symptoms over the 
past month. The first four questions are about weekly alcohol use and include things like, “On 
average, how many days each week did you ever have 5 or more drinks in a row,” which are 
rated on a 5-point scale from 0 (0 days per week) to 5 (7 days per week). The next 11 questions 
are Yes or No questions and ask if in the past month the client’s alcohol use ever led to things 
like “Fights or arguments with family or friends” and “Craving or having strong urges to take a 
drink.” Self-report measures of alcohol consumption and related activities are valid and reliable 
(Del Boca & Darkes, 2003). 
 TCU General Crime, Employment, and Life Status (CEL; Joe et al., 2004). This is a 
10-item self-report questionnaire measuring risks associated with crime, employment, and life 
status over the past month. The first seven items ask questions such as “On average, how many 
days each week did you ever get into fights or loud arguments?” and are scored on a 5-point 
scale with response options ranging from 0 (0 days per week) to 5 (7 days per week). The final 
three items ask questions such as “How many times were you arrested?” scored on a 5-point 
scale with response options ranging from 0 (0-2 times) to 5 (11+ times). This scale is broken into 
four subscales including crime problems, employment problems, life status problems, and CEL 
total. Self-report measures of criminal behaviour and activity have high reliability (Darke, 1998; 
Thornberry & Krohn, 2000). 
 TCU Client Evaluation of Motivation (MOT; Garner et al., 2007; Joe et al., 2002). 
This is a 36-item self-report questionnaire that asks clients about their motivation to be in 
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treatment over the past month. Items are scored on a 5-point scale with response options ranging 
from 1 (Disagree Strongly) to 5 (Agree Strongly). Questions on this scale include things like, 
“You need to be in treatment now” and “You feel a lot of pressure to be in treatment.” This scale 
is broken into five subscales including problem recognition, desire for help, treatment readiness, 
pressures for treatment, and treatment needs. This measure has good internal consistency 
reliability (Simpson et al., 2012) and is reliable for use in treatment programs (Joe et al., 2002). 
 TCU Client Evaluation of Social Functioning (SOC; Garner, Knight, & Simpson, 
2007; Joe, Broome, Rowan-Szal, & Simpson, 2002). This is a 36-item self-report questionnaire 
that asks clients about their level of social functioning over the past month. Items are scored on a 
5-point scale with response options ranging from 1 (Disagree Strongly) to 5 (Agree Strongly). 
Questions on this scale include things like “You have people close to you who can always be 
trusted” and “You like others to feel afraid of you.” This scale is broken into four subscales 
including hostility, risk taking, social support, and social desirability. This measure has good 
internal consistency (Simpson, Joe, Knight, Rowan-Szal, & Gray, 2012) and is reliable for use in 
treatment programs (Joe et al., 2002). 
 TCU Global Risk Assessment - Adult (RSK; Joe, Simpson, Greener, & Rowan-Szal, 
2004). This is an 11-item self-report questionnaire measuring global risk over the past month. 
The first item asks “How much of the time in the past month were you locked up?” and the 
following 10 questions ask a variety of Yes or No questions about the past month including 
things like, “Were you ever employed full time?” and “Were you ever treated in an emergency 
room?” This measure has acceptable test-retest reliability and good internal consistency 
(Bernstein et al., 2010; Broome, Joe, & Simpson, 2001). 
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 Addiction Prevention and Treatment Services’ Methadone Evaluation 
Questionnaire (MEQ; Capital Health, 2005). This is a 13-item self-report questionnaire that 
asks a variety of questions, mostly with Yes or No options, on the subjects of drug use/high risk 
behaviours, housing, employment status, criminal convictions, and family. 
 Verona Service Satisfaction Scale for Methadone Treatment (VSSS-MT; Pérez de 
los Cobos et al., 2002). This is a 17-item self-report questionnaire that asks questions about the 
experience in using the treatment centre’s methadone maintenance therapy program over the past 
month. Questions are rated on a 5-point scale with response options ranging from 1 (Terrible) to 
5 (Excellent). Some questions also include an option for Not Applicable. Questions include 
things like, “What is your overall feeling about the effect of the program in helping you deal with 
your problems?” and “What is your overall feeling about the effectiveness of the program in 
helping you to improve your relationships with your close relatives?” This measure has excellent 
internal consistency, good test-retest reliability, and good concurrent validity (Pérez de los Cobos 
et al., 2002). 
 TCU Client Evaluation of Treatment Engagement (ENG; Garner et al., 2007; Joe et 
al., 2002). This is a 36-item self-report questionnaire that asks clients about their level of 
treatment engagement over the past month. Items are scored on a 5-point scale with response 
options ranging from 1 (Disagree Strongly) to 5 (Agree Strongly). Questions on this scale 
include things like “Your treatment plan has reasonable objectives” and “The staff here are 
efficient at doing their job.” This scale is broken into four subscales including treatment 
participation, treatment satisfaction, counselling rapport, and peer support. This measure has 
good internal consistency reliability (Simpson et al., 2012) and is reliable for use in treatment 
programs (Joe et al., 2002). 
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 Patient Global Impression of Improvement scale (PGI; Trujols et al., 2011). This is a 
one-item self-report measure that asks, “Compared to your condition at admission to the centre, 
how much have you changed?” The answer is rated on a 7-point scale, with response options 
ranging from 1 (Very much improved) to (Very much worse). This measure has demonstrated 
good test-retest reliability and concurrent validity (Srikrishna, Robinson, & Cardozo, 2010). 
 Client Global Impression of Improvement scale (CGI; Guy, 1976; Trujols et al., 
2011). This is a one-item clinician completed measure. Referring to the patient, the question 
asks, “Compared to his/her condition at baseline, how much has he/she changed?” The clinician 
is asked to rate only the improvement that they feel is due entirely to the drug treatment. The 
answer is rated on a 7-point scale, with response options ranging from 1 (Very much improved) 
to (Very much worse). This measure has shown good psychometric properties (Guy, 1976). 
 Patient Opinion of Services (POS; Pérez de los Cobos et al., 2005). This is a one-item 
self-report measure that asks, “Taking into account your overall experience, what is your 
impression about methadone as a medication for carrying out maintenance treatment of opioid 
dependence?” This question is rated on a 5-point scale with response options ranging from 1 
(Terrible) to 5 (Excellent). 
 Open Forum Questions (Capital Health, 2005). Clients have the opportunity to write 
their comments about things they have liked about their experience and things they have disliked 
about their experience.  
Data Analysis 
 To test our first four hypotheses, bivariate correlations were performed, with subsequent 
follow-up linear regressions completed where correlations were significant. Our final hypothesis 
was examined through descriptive analyses that looked at clients’ reported change in drug use, 
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high-risk, and criminal behaviours, housing, employment status, and family support. Other 
descriptive information was examined, such as quality of life and opinions of services. 
Qualitative questions were examined manually for common themes and summarized.  
Results 
Social Desirability and Accurate Responding 
 The TCU Client Evaluation of Social Functioning scale contained a subscale measuring 
social desirability. Scores on this measure were explored for each client, with higher scores 
representing possible biased responding. The mean score on this subscale was 6 (SD = 2.53), 
with a maximum score possible of 11. This suggests that there may have been a bias towards 
responding desirably. Also, when relating self-rated improvement to clinician-rated improvement 
only a weak correlation was found (see Table 1). Most individuals rated themselves as slightly 
more improved compared to ratings of improvement by staff at the treatment centre. This also 
suggests possible biased responding. 
 Three measures completed by clients also included checks for accurate responding. The 
TCU Client Evaluation of Psychological Functioning, the TCU Client Evaluation of Motivation, 
and the TCU Client Evaluation of Social Functioning measures contained items that requested a 
specific answer (e.g., “Please fill in the ‘Uncertain’ box as your response for this question.”). 
Client’s responses to these items were checked for accuracy and where items were answered 
inaccurately or left blank, total scale scores for the individual were compared to average scale 
scores on the measure of the entire sample. There were no issues of importance to note.  
Bivariate Correlations and Linear Regressions 
 The relationships between self- and clinician-rated improvement and motivation and 
engagement scores were explored through bivariate correlations (see Table 1) with no 
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statistically significant findings. While not statistically significant, the directions the variables 
correlated in provided a meaningful indicator of how the variables interact, therefore these 
relationships were included in our results. Relationships with r values of less than ±.20 
represented very weak correlations and are not discussed. Self-rated improvement correlated 
positively with all subscales of treatment engagement, which suggests that greater improvement 
is related to greater engagement and vice versa. Clinician-rated improvement correlated 
positively with all treatment engagement subscales as well, again, suggesting that greater 
improvement is related to greater engagement. Self- and clinician-rated improvement had 
negligible correlations with all motivation subscales, which suggests a very weak relationship 
between improvement and motivation.  
 The relationships between self- and clinician-rated improvement and quality of life, 
psychological functioning, psychological distress, physical health, social functioning, problems 
with alcohol, criminality, employment difficulties, life difficulties, and overall risk scores were 
explored through bivariate correlations (see Tables 2-4) and where correlations were significant, 
through linear regressions (see Table 5). Self-rated improvement correlated significantly in a 
positive direction with scores on the expectancy subscale of the psychological functioning 
measure, indicating that those with greater self-rated improvement had a lower expectancy to use 
drugs or relapse in the past month. Regression analysis revealed that expectancy accounted for 
14.9% of the variance in self-rated improvement and vice versa. Self-rated improvement also 
correlated significantly in a negative direction with scores on the life status problems subscale of 
the crime, employment, and life measure, indicating that those with greater self-rated 
improvement had less life status problems in the past month. Regression analysis revealed that 
life status problems accounted for 16% of the variance in self-rated improvement and vice versa. 
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 Aside from these two significant findings, correlational significance was not observed 
between these variables and self- or clinician-rated improvement. Again, however, the directions 
of the correlations provided an indicator of how the variables interact. Self-rated improvement 
correlated positively with self-esteem, decision-making, family relationships, and peer 
socialization, suggesting that greater improvement relates to greater self-esteem, better decision-
making, and greater family and peer relationships. Self-rated improvement correlated negatively 
with depression, peer criminality, life status problems, and overall problem scores, suggesting 
that greater improvement relates to less depression, less association with peers who are 
committing crimes, and to less life status and overall problems. Clinician-rated improvement 
correlated positively with decision-making, expectancy, physical health, peer socialization, and 
overall risk scores, suggesting that greater clinician-rated improvement relates to better decision-
making, less expectancy to use drugs or relapse, greater peer relationships, and lower risk. 
Clinician-rated improvement correlated negatively with depression, hostility, crime related 
problems, life status problems, and overall problems, suggesting that clinician-rated 
improvement relates to less depression and hostility, and less crime related, life status, and 
overall problems. 
 The relationships between self- and clinician-rated improvement and opinion of services 
were explored through linear regressions (Table 6). Both self- and clinician-rated improvement 
significantly predicted opinion of services, indicating that greater improvement leads to a greater 
opinion of services. Opinion of services accounted for 17.3% of the variance in self-rated 
improvement and 14% of the variance in clinician-rated improvement. 
 The relationships between opinion of services and engagement and motivation scores 
were explored through bivariate correlations (Table 7) and where correlations were significant, 
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through linear regressions (see Table 8). Opinion of services correlated significantly in a positive 
direction with scores on the treatment participation, counselling rapport, and peer support 
subscales of the engagement measure, indicating that those with a higher opinion of services had 
greater participation in treatment, had better relationships with counsellors, and had better 
support from peers. Regression analysis revealed that patient opinion of services accounted for 
18% of the variance in treatment participation, 23.3% of the variance in counselling rapport, and 
16% of the variance in peer support. Opinion of services correlated significantly in a negative 
direction with scores on the problem recognition subscale of the motivation measure, indicating 
that those with a higher opinion of services had less recognition of having a drug use problem. 
Regression analysis revealed that patient opinion of services accounted for 31.1% of the variance 
in problem recognition.  
 No further significant results were observed, however, the directions the variables 
correlated with the subsequent subscales provided an indicator of how the variables interact. 
Opinion of services correlated positively with the remaining engagement subscale, treatment 
satisfaction, suggesting that a positive opinion of services relates to greater satisfaction with 
treatment. Opinion of services also correlated negatively with the desire for help and pressures 
for treatment subscales of the motivation measure, suggesting that a more positive opinion of 
services relates to less desire for help and less pressures for treatment. 
Descriptive Information  
 The majority of clients in the methadone maintenance treatment program at Cree Nations 
Treatment Haven (n = 24; 80%) reported a decrease in drug use and high-risk behaviours since 
admission to the program. Forty percent of clients (n = 12) reported a decrease in criminal 
behaviour since admission and 40% (n = 12) reported no decrease in criminal behaviour, while 
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20% of clients (n = 6) chose not to answer this question; 13.3% of clients (n = 4) reported having 
new criminal convictions since admission to the program. Seventy percent (n = 21) reported that 
their housing condition improved since admission, and 73.3% (n = 22) reported having adequate 
housing. Most clients reported an improvement in employment status (n = 17; 56.7%), although 
43.3% of clients (n = 13) reported themselves as unemployed. The majority of clients reported an 
increase in family support since admission (n = 23; 76.7%), and 93.3% (n = 28) reported having 
family support. Most clients (n = 20; 66.7%) reported an average quality of life, 26.7% (n = 8) 
reported a very good quality of life, and 6.7% (n = 2) reported a poor quality of life. Those who 
scored in the poor range on this measure of quality of life were at most, only two points away 
(out of 140) from being in the average quality of life range. Clients’ opinions of the services 
provided at Cree Nations Treatment Haven were positive. These results can be seen in Tables 9 
and 10.  
Qualitative Data 
 Two qualitative questions were asked and manually examined for common themes. Both 
questions yielded useful data. The first question, “The thing I have liked most about my 
experience of the methadone program is:,” was answered by 93.3% (n = 28) of clients. Seven 
common themes emerged from this question including being off of drugs, program praise, new 
beginnings and pride, social relationships, money, psychological health, and physical health. The 
first theme, being off drugs, was the most highly recognized with 64.3% (n = 18) commenting in 
this area. This theme included things like not chasing drugs and not having to worry about 
getting the next fix, being sober, and not getting/being “dope sick” anymore. Others also made 
comments about no longer having cravings and staying off of “hardcore” drugs.  
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 The next most dominant theme, program praise, was recognized by 53.6% (n = 15). 
Under this theme individuals mentioned things like the program’s closeness to home, learning 
that others experience similar difficulties, the caring and supportive staff, and the program’s 
effectiveness when you follow it. Many individuals used this portion of the questionnaire to 
thank the program and its staff for their help. New beginnings and pride was another dominant 
theme with many individuals reporting things like having their life back, having their life saved, 
enjoying life, being proud of themselves, and feeling worthy. Individuals also reported freedom, 
stability, feeling like a good person, and achieving success as positive outcomes of the program. 
This theme was recognized by 42.9% (n = 12).  
 Many clients endorsed the theme of social relationships with ideas surrounding positive 
change in different relationships commonly appearing. Individuals reported things like being 
closer to and having more time for their families and others, being more reliable, receiving 
respect from children and others, getting along with everyone, and being grateful that there are 
people who care. This theme was recognized by 39.3% (n = 11). Under the theme of money, 
things like having money to spend, being more responsible with money, and not always trying to 
save money for drugs or alcohol emerged. Employment was also mentioned as a positive 
outcome of the program. This theme was recognized by 21.4% (n = 6). 
 Psychological health also emerged as a common theme, with individuals reporting things 
like being able to think more clearly and cope with thoughts, having time to better oneself, and 
having a better relationship with God or religion. This theme was recognized by 21.4% (n = 6). 
Under the theme of physical health, individuals reported improved sleep and feeling healthy 
again. One individual also noted remaining arthritis pain, but a belief that this pain would go 
away with continued treatment. This theme was recognized by 14.3% (n = 4). 
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 The second question, “The thing I have disliked most about my experience of the 
methadone program is:,” was answered by 86.7% (n = 26). Four themes emerged out of the 
responses to this question including being on/getting methadone, social concerns, other treatment 
programming interests, and recommendations. Under the theme of being on/getting methadone, 
many individuals commented on not having enough time to get to the treatment centre, not being 
permitted carries, and having to walk a long way to the centre (especially in the winter). Some 
also mentioned things like incorrect dosing, worry about relapse, weight gain, and the doctor’s 
discouragement surrounding discontinuing methadone. This theme was recognized by 80.8% (n 
= 21). Under the theme of social concerns individuals reported things like people gossiping or 
making assumptions about those in the program, people abusing the program, and difficulty 
finding employment because of the program’s methadone dispensing times. This theme was 
recognized by 15.4% (n = 4). 
 The theme of recommendations was recognized by 23.1% (n = 6). Recommendations 
surrounded different or longer dispensing times, allowing carries to those who are doing well, 
providing transportation for those who need it, and allowing everyone to have one male and one 
female counsellor. Under the theme of other programming interests individuals mentioned a lack 
of after work programming, concerns with only being permitted to have one counsellor, and an 
interest in switching to suboxone. This theme was recognized by 11.5% (n = 3). Two individuals 
(7.7%) also reported having no dislikes about the methadone program. 
Discussion 
 
 The purpose of this study was to evaluate the methadone maintenance therapy program at 
Cree Nations Treatment Haven. Results demonstrated that individuals in treatment reported a 
decrease in drug use and high-risk behaviours, and improvements in housing, employment status, 
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and family support since admission to the program. Individuals with higher rated improvement 
reported greater engagement, life quality, psychological functioning, physical health, and 
relationships with family and friends. Improvement also related to less psychological distress, 
problems with alcohol, criminality, employment and life difficulties, and overall risk. Higher 
rated improvement also correlated with a more positive opinion of services, and those with a 
positive opinion of services reported higher treatment engagement. It was also hypothesized that 
improvement and opinion of services would relate to higher motivation, however very weak 
correlations were found.  
 Results suggested a bias towards socially desirable responding; however, the utility of 
measuring socially desirable response styles to validate self-report measures has been 
questioned. Uziel (2010) reported that of over 2,500 published studies that include measures of 
socially desirable responding, these scales have mostly failed to detect deception. This is not to 
say that there are no biases in self-reports; however, it advises that response bias should not be 
assumed from results on another self-report measure. Also, in samples of substance users, higher 
levels of socially desirable responding have been observed when individuals are using substances 
less often (Zaldivar, Molina, Lopez Rios, & Garcia Montes, 2009). Higher rates of social 
desirability have also been found to relate to longer periods in treatment (Zenmore, 2012). 
Because most of the individuals included in this evaluation have been in treatment for long 
periods of time and are no longer abusing substances, slightly elevated levels of socially 
desirable responding are expected and acceptable.  
 Cultural differences in self-presentation may also affect responding on social desirability 
scales. Cultural characteristics such as power distance, collectivism, uncertainty avoidance, and 
extraversion have been found to influence response styles, as well as respondents’ proficiency 
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with the language of the questionnaire items (Harzing, 2006). Because of these cultural aspects, 
it is possible that the scale used may have over-identified socially desirable responding in the 
current group.  
 Clients in the methadone maintenance therapy program reported greater self-rated 
improvement overall when compared to clinician ratings. It has been considered that individuals 
may recognize their own improvement in different ways than the clinicians, and the clinicians 
may not have insight into all areas of an individual’s life; therefore the clients’ ratings are 
accepted as reliable. Self-report has frequently been overlooked as an outcome measure in 
substance use research (Darke, 1998; Del Boca & Noll, 2000); however, this study affirms the 
utility of measuring subjective experience, as has been suggested in the literature.  
 Greater levels of engagement in treatment were related to greater overall improvement; 
the more engaged an individual was in treatment, the more improvement they experienced. A 
similar relationship was also expected between motivation towards treatment and level of 
improvement, however correlations were not significant. Because motivation was measured as 
problem recognition, desire for help, treatment readiness, pressures for treatment, and treatment 
needs, it is possible that client endorsement of motivation showed a ceiling effect. That is, 
individuals who are experiencing substantial improvements in functioning may no longer feel 
they have a problem with substance abuse, desire help, be ready for treatment, experience 
pressure from others to enter treatment, or feel that treatment is needed at this time.  
 The fact that individuals are no longer highly motivated to be in treatment may actually 
signify a greater level of improvement, as individuals may feel that they have overcome their 
addiction. The type of motivation measured with the scale used may represent a motivation to 
begin treatment, rather than continue with treatment. It is likely that through the engagement and 
EVALUATING AN ON-RESERVE MMT PROGRAM 52 
motivation measures used, engagement measured the dedication to continue treatment, while 
motivation measured the desire to begin treatment. With engagement and motivation measured 
in this way, it is understandable that engagement would have a stronger relationship with 
improvement than motivation in the current group. 
 Greater improvement was related to a lower expectancy to use drugs or relapse in the past 
month, which shows that those who are doing well see little chance of relapse. This suggests that 
clients who are doing well have little or no intention to use drugs and may believe they can 
effectively deal with drug-related cues as they arise. Greater improvement also related to less life 
status problems, where life status problems included things like spending little time doing 
“sober” activities with family or friends, not attending self-help meetings, not having a regular 
place to live and sleep, and getting in arguments or fights. This relationship shows that the more 
clients feel they have improved, the less difficulties in life they seem to be having.  
 Greater improvement was related to greater self-esteem, better decision-making, and 
greater family and peer relationships as well. These findings are supported by the self-medication 
hypothesis of addictive disorders, which suggests that individuals use substances to relieve or 
change painful affect states (Khantzian, 1997). Self-medication occurs during the course of 
difficulties with self-esteem, relationships, and self-care (Khantzian, 1997). The relationship 
between improvement and self-esteem, decision-making, and social relationships suggests that 
individuals may be less likely to use substances to self-medicate, which may lead to greater 
overall improvement.  
 While improvement was found to relate to better decision-making, Wang and colleagues 
(2012) found that drug-related cues continued to interfere with decision-making in former heroin 
addicts after being drug free for between 1 and 24 months. This suggests that while strong 
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decision-making skills are important to recovery, individuals may need other strategies in place 
to avoid relapse, specifically surrounding the reduction of drug-related cues. The present study 
found that individuals are not only strengthening decision-making skills, but are also improving 
in other areas of life functioning, which can help reduce the likelihood of reacting to drug-related 
cues.  
 The relationship between improvement and having better family and peer relationships is 
supported in the literature. For example, Lavee and Altus (2009) found that those who remained 
drug-free had closer relationships with family members. Also, some First Nations populations 
understand health as a state of balance across all aspects of life, including social aspects (Dell et 
al., 2012), therefore this relationship between improvement and family and peer relationships 
may contribute to the balance of health. 
 Self-rated improvement was associated with fewer subjective depressive symptoms, less 
association with peers who are committing crimes, and less overall problems. Depression, 
negative social support, and overall problems are risk factors for relapse. Davis and O’Neill 
(2005) found that thinking differently about life, maintaining self-care, and relying on positive 
social support (all factors protecting against depression) are important strategies for relapse 
prevention. Drug Policy Alliance (2006) indicated depression as a common reason for relapse as 
well. When individuals are less depressed they may have less of a need to self-medicate with 
substances. Also, individuals report the association with criminally involved peers as one of the 
most difficult, yet crucial parts of changing substance using behaviour (Anstice et al., 2009). The 
relationship between association with criminally involved peers and improvement suggests that 
the treatment program may be overcoming this common and difficult challenge. Additionally, 
greater clinician-rated improvement was associated with less hostility. Because Aboriginal 
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individuals who use opioids have more difficulty managing aggressive behaviour than their non-
using counterparts (Jacobs & Gill, 2002), their improvement may be helping to reduce hostility. 
 Both self- and clinician-rated improvement predicted opinion of services indicating that 
the more an individual improved, the greater opinion of services they reported. A more positive 
opinion of services was also related to greater engagement; those who participated more in their 
treatment had a better opinion of services. The relationships developed with the counselors at the 
centre related to opinion of services, as well as support from peers in the program. This suggests 
that relationships and support from staff and peers are important to individuals in treatment.  
 Due to the history of colonization that Aboriginal individuals have faced, effective 
relationships between therapists and Aboriginal clients often take more time to grow when 
therapists are of a different cultural background (Wing et al., 1995). While demographic 
information was not collected from the therapists and staff at the treatment centre, this 
information may have clarified the meaning of this result. Regardless of the demographics of the 
staff at the centre, the association between relationships with staff and peers at the centre and 
opinion of services suggests that these relationships are meaningful to clients. Particularly 
surrounding the implication of peer support, it has been found that group cohesion and support is 
instrumental in ensuring continued program adherence (Rawson & McCann, 2005). 
 A greater opinion of services was also related to less motivation, specifically, less 
recognition of having a drug use problem, less desire for help, and less pressure for treatment. 
Similar to the relationship between greater improvement and less motivation, those who rated the 
program more positively may no longer feel that their drug use is a problem, desire help, or feel 
pressure to be in treatment because of the help the program has provided thus far. The low 
motivation shown by clients does not suggest that clients are not motivated for ongoing 
EVALUATING AN ON-RESERVE MMT PROGRAM 55 
treatment, but instead suggests that the program has helped to the extent that clients no longer 
feel that they have a substance abuse problem, desire help, or feel pressure to be in treatment. 
 While the majority of clients in the present evaluation reported a decrease in drug use and 
high-risk behaviours since admission to the program, less than half reported a decrease in 
criminal behaviour. The individuals who reported no decrease in criminal behaviour may have 
answered this way because they were not engaging in criminal behaviour before beginning 
treatment; also, many chose not to answer this question and the reason for this is unknown. A 
higher rate of criminal activity was reported in the present evaluation than the original evaluation 
of Cree Nations Treatment Haven completed in 2012. The current evaluation, however, asked 
about criminal convictions since beginning treatment, while the previous evaluation looked at 
past 30-day criminal involvement. Given that most individuals have been in treatment for many 
years, the slightly higher rate of new criminal convictions may reflect the difference in the time 
period being referred to, rather than an increase in convictions since the initial evaluation. It is 
also possible that clients were ambivalent about reporting criminal activity due to being 
identifiable by treatment centre staff. While clients were anonymous to the evaluators, they were 
not anonymous to the staff at the treatment centre. 
 The majority of clients in the present evaluation reported an improvement in their 
housing condition since beginning methadone treatment and also reported having adequate 
housing. The improvement in housing condition for those in the treatment program is important 
for individuals living in First Nations communities particularly, as a large majority of First 
Nations people in Canada have identified housing as a major concern in the past (First Nations 
Information Governance Centre, 2011). The literature explains that achieving adequate housing 
can begin a process of change so that as an individual’s living situation begins to improve, other 
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areas of daily functioning can improve and be maintained (Tsemberis, 2010). While substance 
abusing individuals are often classified as “hard to house” due to difficulties maintaining 
sobriety, gaining permanent housing is frequently associated with participation in treatment for 
substance abuse and sobriety (Tsemberis, 2010). 
 The improvement in employment status is also a success of Cree Nations Treatment 
Haven’s methadone maintenance therapy program. While slightly less than half of the current 
group reported themselves as unemployed and this unemployment rate is much higher than it is 
for the general population, the majority of clients reported that their employment status had 
improved since beginning treatment. The initial evaluation of Cree Nations Treatment Haven’s 
methadone maintenance therapy program reported that 73.7% of clients were unemployed; this 
indicates that in 3 years, the unemployment rate among clients has dropped by 30% and it is now 
lower than the average unemployment rate of adults living on-reserve in northern First Nations 
communities in Saskatchewan (47.2%; First Nations Information Governance Centre, 2011). 
Because individuals with poor health are more likely to be economically disadvantaged and have 
more difficulties overcoming their economic hardships compared to those with better health 
(Bloom & Canning, 2000), the improvement in employment status may signify an improvement 
in health. 
 An improvement in education status was also found. In the initial Cree Nations Treatment 
Haven study 2.6% had any level of post-secondary education, while the current study found 
23.3% with some post-secondary education and 6.7% with post-secondary education completed. 
These results suggest that in the 3 years since the previous study was completed, some 
individuals have received further education. The increased wellbeing and stability that clients 
gain from participation in the program may allow them to pursue further education. 
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 Research has found that Aboriginal individuals who abuse substances report being 
extremely bothered by family issues and have difficulty getting along with friends (Jacobs & 
Gill, 2002); however, most clients at Cree Nations Treatment Haven reported an increase in 
family support since admission and almost all clients reported having family support. While 
clients reported an increase in family support, further research may clarify if the methadone 
maintenance therapy program increases family values, which in turn, contribute to better health 
and a stronger overall community. Family values have been ranked as a community strength in 
the past (First Nations Information Governance Centre, 2011), so the identification of such a 
relationship would suggest the strengthening of the community.  
 Almost all clients rated their quality of lives in the average or very good ranges, and only 
two individuals scored in the poor range on quality of life; the scores for these two individuals, 
however, were on the borderline of average quality of life. Typically when discussing quality of 
life, methadone maintenance therapy clients mention themes of social relationships, 
psychological wellbeing, occupation status, independence, and having a meaningful life (De 
Maeyer et al., 2011). Most of these themes emerged throughout this evaluation. 
 Demographic results showed that males and females were accessing the methadone 
maintenance treatment equally, suggesting that the program is accessible to both sexes. While 
women experience opioid related problems more often, they tend to seek treatment less 
frequently than men (Health Canada, 2011); however, it appears that Cree Nations Treatment 
Haven may be overcoming some of the barriers women face when seeking treatment.  
 The age range of clients accessing services at Cree Nations Treatment Haven is broad, 
revealing that the program is appropriately reaching most age groups. There is, however, a gap in 
clientele between the ages of 17 and 23. Cree Nations Treatment Haven accepts clients aged 17 
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and older, however the youngest client receiving methadone maintenance treatment currently is 
23 years old. This suggests that the treatment program may not be reaching younger individuals 
appropriately, as First Nations people tend to start using substances at a younger age (First 
Nations Centre, 2005). 
 Many clients at Cree Nations Treatment Haven did not report the date they began 
treatment. Of those who reported a treatment start date, four individuals had been in treatment 
for 5 or more years, four clients for 4 years, one client for 3 years, five clients for 2 years, and 
two clients for 1 year or less. Because Cree Nations Treatment Haven’s methadone maintenance 
therapy program began in January of 2011, individuals in treatment for longer than 4 years may 
have begun methadone treatment elsewhere before transferring to Cree Nations Treatment 
Haven. While these lengths in treatment are only estimations of initiation and may include 
treatment beginning prior to the opening of Cree Nations Treatment Haven’s methadone 
maintenance therapy program, they suggest success for individuals in treatment. Research has 
found that individuals who remain in methadone maintenance treatment for 3 years or more tend 
to have better success in all areas of functioning (Kreek & Vocci, 2002).   
 Clients rated the services received at Cree Nations Treatment Haven positively. The 
majority of clients felt excellent or mostly satisfied about all aspects of the program, including 
the program’s effectiveness at helping them deal with their problems, the information given 
about their addictions, instructions received regarding self-care, and help received to deal with 
the side effects of methadone. One area that was rated positively, but left room for improvement 
was clients’ feelings about the instructions they were given for what to do on their own between 
appointments. The majority of clients felt mostly satisfied or had mixed feelings about this, 
which suggests that further direction could be provided on activities of daily living.  
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 The majority of clients felt either excellent or mostly satisfied about methadone as a 
maintenance medication, considering their overall treatment. There is often a belief that 
methadone has worse side effects and withdrawal symptoms than other opioids and that 
methadone treatment is too disciplinary, controlling, regimented, and disempowering (Fischer et 
al., 2002). Individuals receiving treatment at Cree Nations Treatment Haven, however, report an 
accepting attitude of methadone maintenance therapy as an overall treatment for opioid use 
problems, suggesting that the current group may not hold these common beliefs about 
methadone. 
 The majority of clients felt either mostly satisfied or mixed feelings about the program’s 
effectiveness at helping close relatives to better understand their problems, suggesting an area for 
improvement. While providing services and education for family members of clients may not be 
a direct priority of methadone maintenance treatment, programming that educates family 
members on their loved ones’ struggles can assist the client’s development of effective social 
functioning. 
 The majority of clients felt excellent or mostly satisfied with the personal manner of the 
staff, the knowledge the staff had about their past diseases, and the overall ability of the staff to 
listen to and understand problems. A good relationship with the staff who dispense the 
medication has been listed as an important factor to those receiving treatment (Anstice et al., 
2009); in fact, the stigma associated with methadone use and discrimination experienced from 
dispensing staff are the most powerful forces preventing people from entering methadone 
treatment (Joseph et al., 2000; National Institutes of Health, 1999). Positive reports such as this 
may assist in encouraging others to enter treatment in the future. 
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 Most individuals reported that they received help to improve their capacity to cope with 
life. Most who received this help were satisfied and no clients who had not received the service 
reported wishing they had. Few clients received practical help at home from the program, but 
those who did rated these services highly. Of those who did not receive these services, however, 
some would have liked to and this represents an area for future consideration.  
 Few clients had the opportunity to take part in leisure activities organized by the 
treatment centre and those who did were either mostly satisfied or had mixed feelings. Of those 
who were not given this opportunity, many reported they would have appreciated the option. 
This indicates clients’ desires for leisure activities to be included as a part of programming. This 
may suggest that the treatment centre is creating an environment where people want to be 
involved. The majority of clients had not taken part in the Matrix program at the centre in the 
past month, but some would have liked to, which is another area for improvement. Of those who 
did take part, the program was rated highly. Few clients reported receiving help in joining 
activities outside of the program, but many would have liked to, which is also an area for 
improvement. Those who did receive these services rated them highly.  
 Themes that emerged out of the open-ended questions were congruent with the opinion of 
services results, with the addition of details. The most common theme that emerged as the most 
liked aspect of the methadone program was being off drugs, followed by program praise, and 
new beginnings and pride. These themes show that in the eyes of the clients, the program is 
making a positive difference and is well received. The other themes that emerged in this area 
included social relationships, money, psychological health, and physical health. All of these 
things are indicators of an effective substance use treatment program as they are directly related 
to reduced substance use (Capital Health, 2005; Currie & Wild, 2012; De Maeyer et al., 2011; 
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Veilleux et al., 2010). Clients noticed and described improvements in everyday functioning, and 
recognizing these changes from the perspectives of the clients is essential to appreciating 
program success. 
 Four themes emerged as the least liked aspects of the program, including being on/getting 
methadone, social concerns, other treatment programming interests, and recommendations. 
Many of the concerns presented are consistent with program evaluation literature and not unique 
to Cree Nations Treatment Haven. For example, Chong and Herman-Stahl (2003) reported client 
concerns of few treatment choices, inconvenient treatment hours, and a lack of transportation to 
treatment centres. 
 The qualitative questions also allowed for the presentation of recommendations from the 
clients’ perspectives. If improvements were to be made to the program, the clients’ opinions and 
recommendations would be an excellent place to look for guidance. Individuals expressed 
concern about dealing with side effects and worries of relapse. The social stigma clients felt from 
the community was also presented as a concern. Clients requested longer dispensing times that 
would allow them more employment opportunities, transportation to and from the treatment 
centre (especially in the winter), and being assigned both a male and female counselor.  
 Another common recommendation arose surrounding the allowance of take-home doses 
of methadone, also known as carries. This was a frequent request, and while clients’ opinions 
should be considered, evidence suggests a large decrease in risk with the prohibition of carries. 
There is a serious concern of the possibility of household members, such as children, 
accidentally ingesting methadone when individuals are permitted to have their methadone at 
home (Smialek et al., 1977; Ward et al., 1999). Clients could also potentially ingest more than 
their prescribed dose of methadone or divert their medication to others (Ward et al., 1999). Often 
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this diversion of methadone is for altruistic reasons, for example, helping a friend avoid 
withdrawal symptoms, but this does not minimize the risk.  
 Methadone maintenance therapy programs that allow carries have stringent controls in 
place to minimize risks, such as ensuring a good drug-response and relationship with the 
treatment centre staff before allowing carries. Other risk prevention strategies include educating 
clients of the risks associated with having their methadone at home and providing childproof 
containers and lockboxes for the methadone (Peles et al., 2011; Ward et al., 1999). While there 
are ways to effectively minimize risks associated with methadone carries, the only way to 
eliminate these risks is by not permitting clients to have any take-home doses.  
 Finally, there were requests for additional programming, such as increased after-work 
program availability and the addition of suboxone as a treatment option. Suboxone is another 
medication used for long-term maintenance treatment and is a combination of buprenorphine and 
naloxone. Buprenorphine is the main component of this maintenance medication, but it is 
combined with naloxone to prevent abuse. Buprenorphine is a partial agonist at the µ receptor, 
(Jones, 2004) and it has been available since the 1980s in low doses to treat pain (Parks Thomas 
et al., 2014). It has similar effects to methadone, but is less intense and also detaches from the µ 
receptor more slowly, which makes it effective when taken every other day or even less 
frequently (Jones, 2004).  
 Buprenorphine also produces less respiratory depression or overdose risk compared to 
other opioids and has milder withdrawal symptoms; however, it does present some abuse 
potential when not combined with naloxone (Jones, 2004). While buprenorphine blocks other 
opioids from reaching receptors and producing effects, it can be injected into the bloodstream 
and will cause euphoric effects this way (Jones, 2004). The solution to this problem is the 
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addition of naloxone, which induces withdrawal symptoms when it is injected, but not when 
taken orally (Jones, 2004; Parks Thomas et al., 2014). This combined substance, known as 
suboxone, is a relatively new treatment for opioid addiction that is presently being researched as 
an alternative to methadone (Parks Thomas et al., 2014). Because of suboxone’s low potential 
for abuse, it may be a good option for beginning opioid dependence treatment or for those who 
do not have access to or meet criteria for a methadone maintenance program (Fudala et al., 2003; 
Jones, 2004). 
 Studies investigating the effectiveness of suboxone compared to placebo have achieved 
positive results (Amato et al., 2005; Fudala et al., 2003; Kakko, Svanborg, Kreek, & Heilig, 
2003; Ling et al., 1998; Mattick, Breen, Kimber, & Davoli, 2014). Suboxone has been found to 
have less drug interactions than methadone, especially with HIV medications, but several 
overdoses have been reported, particularly when high doses are combined with benzodiazepines 
(McCance-Katz, Sullivan, & Nallani, 2010; Reynaud, Petit, Petard, & Courty, 1998; Singh, 
Mattoo, Malhotra, & Varma, 1992). While suboxone is effective in treating opioid dependence in 
some circumstances, methadone is currently the gold standard in opioid dependence treatment.  
 With appropriate dosing, methadone is consistently the most effective treatment, but not 
by so much that suboxone is advised against (Mattick et al., 2014). Research has shown no 
differences in unwelcome side effects between suboxone, placebo, or methadone, but greater 
retention and less illicit opioid use is most often seen with methadone, which is important to 
opioid dependence treatment due to the high potential for relapse (Amato et al., 2005; Mattick et 
al., 2014). It is suggested that suboxone treatment be used in situations where high doses of 
methadone are not possible or for clients who do not react well to methadone (Johnson et al., 
2000; Mattick et al., 2014).  
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Limitations and Future Directions 
 The results of this evaluation must be interpreted while considering some limitations. 
First, the sample size in this study was small, however, the present sample contained half of the 
clients in treatment at Cree Nations Treatment Haven. Because the purpose of this study was to 
evaluate the methadone maintenance therapy program at Cree Nations Treatment Haven, the 
relationships found may be meaningful despite not reaching statistical significance. The 
relationships and descriptive information discussed provide indicators of the numerous strengths 
and minimal limitations of the program.  
 This evaluation intended to incorporate the entire in treatment population at the centre 
and a waitlist control group; however, Cree Nations Treatment Haven is a busy treatment centre 
with clients to provide for. Because of the requirements of operating a treatment centre, 
completion of evaluation measures may need to be set-aside during particularly demanding 
times. Due to the nature of secondary data analysis, particularly the need to maintain the 
anonymity of the clients to the evaluators, the researchers were unable to provide assistance to 
the centre in completing the evaluation measures. While assistance may have allowed for quicker 
completion of the entire evaluation, the researchers felt it was important to continue with the 
procedure of a secondary data analysis to ensure Cree Nations Treatment Haven’s ownership of 
the data. 
 The administration of the questionnaires was another limitation of the present evaluation. 
There is concern that questionnaires may have been provided to all clients in treatment at the 
beginning of the evaluation to take home and return upon completion. This is a concern because 
there is a risk that the clients who returned their questionnaires and are included in this 
evaluation are more improved than those who did not. Perhaps those who did not return the 
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questionnaires are continuing to struggle with their substance use or have less positive opinions 
of the treatment centre, and therefore chose not to return their questionnaires. While all clients 
were anonymous to the evaluators, they were not anonymous to the staff at the treatment centre. 
This may have caused a bias in the current sample; however, this issue is yet to be verified with 
the treatment centre. 
 There was also concern with the reporting of treatment entrance dates as many clients 
were unsure of when they began treatment. This limited the exploration of how improvement and 
outcome factors related to time spent in treatment. This could be addressed in the future stages of 
the evaluation by gathering treatment entrance dates from the centre’s records. Also, many 
clients reported beginning methadone maintenance therapy prior to Cree Nations Treatment 
Haven’s methadone maintenance therapy program creation, which presents the possibility that 
centres other than the one being evaluated were included in clients’ responses. This concern will 
be addressed in future evaluations.  
 One of the questionnaires included in the package, the User Generated Outcomes 
measure (Ruefli & Rogers, 2004), was not completed consistently. There was confusion about 
how to complete this measure, but in the future, staff supervising the completion of the 
questionnaires will be specifically educated on instructions to provide, or the instructions for the 
measure will be reviewed for clarity. In future evaluations a different motivation measure should 
be used for clients in treatment. The motivation measure should ask specifically about motivation 
to continue with treatment, rather than to begin treatment. It would also be helpful to ask 
individuals about relapse incidents while in treatment as relapse rates among Aboriginal 
populations are between 35 and 85%, and relapse most often occurs within 90 days (Chong & 
Herman-Stahl, 2003; Wiebe & Huebert, 1996). This is a major component of treatment for 
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opioid using individuals and understanding how relapse occurs during treatment would further 
identify strengths or areas for improvement.  
 Finally, future evaluations should investigate clients’ feelings about the cultural aspects 
of the methadone maintenance therapy program at Cree Nations Treatment Haven and their 
personal identification with culture. The degree to which First Nations individuals identify with 
culture is a protective factor associated with substance use (Bals et al., 2011; Fleming & 
Ledogar, 2008; McIvor & Napoleon, 2009). A recent scoping literature review found evidence 
from 19 studies showing that culturally-based interventions for Indigenous individuals with 
addictions may be effective at improving functioning in all areas of wellness (Rowan et al., 
2014). Understanding clients’ identification with culture and opinions about the cultural aspects 
of the treatment program would solidify some of the programs’ strengths and identify some areas 
for improvement. It would also be helpful in future studies to develop or use already developed 
culturally relevant measures, such as the Native Wellness Assessment (NWA), which is a 
holistic strengths-based measure that focuses on the relationships in a client’s life and reflects the 
impact of cultural programming on client wellness (Dell, 2012). 
Conclusion 
 The use of alcohol and drugs is currently rated as the most significant issue faced by First 
Nations communities in Canada (First Nations Information Governance Centre, 2011), which is 
further underscored by the high rates of mortality and morbidity resulting from opioid use 
worldwide (Brown & Lawrence, 2009). While opioid-related problems are not fully documented 
yet in First Nations populations, the frequency of opioid-related emergency room visits 
(Canadian Centre on Substance Abuse, 2013), and the higher prevalence of illicit prescription 
drug use disorders in First Nations populations (Currie & Wild, 2012; Elton-Marshall et al., 
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2011; Wardman et al., 2002) suggest challenges. Aboriginal individuals are less likely to initiate 
methadone maintenance therapy and Aboriginal identity is consistently negatively associated 
with methadone maintenance therapy (Kerr et al., 2005; Wood et al., 2007) due to financial, 
geographic, and cultural factors. Because of this, the development and evaluation of culturally 
relevant treatment programs is imperative to appropriately address the issue of opioid use in First 
Nations communities. 
 Substance use treatment commonly focuses on the goal of abstinence, with little attention 
to the quality of life of those who use substances. Harm reduction methods of treating substance 
use, however, aim to address more than substance dependence; harm reduction programs have a 
goal of reducing the severity of problems associated with substance use, and in turn, enhancing 
the quality of life of those who use substances (Joseph et al., 2000; Ruefli & Rogers, 2004). 
Considering this harm reduction approach, the outcomes of the beginnings of the evaluation of 
Cree Nations Treatment Haven’s methadone maintenance therapy program are promising. While 
some limitations have emerged, the positive opinions of services endorsed and the improvements 
in everyday functioning reported indicate that the program is succeeding in the eyes of the 
clients. Future evaluation is likely to solidify the present findings and support the community 
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Table 1 
 
Bivariate Correlations Between PGI, CGI, MOT, and ENG Scales 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. PGI  .23 -.11 .05 .11 -.12 .09 .30 .27 .31 .27 
2. CGI   -.11 .00 .12 -.12 -.04 .37 .24 .28 .20 
3. MOT Problem Recognition    .60** -.06 .83** .28 -.52* -.40 -.53* -.48* 
4. MOT Desire for Help     .46* .52* .39 .15 -.08 .18 .29 
5. MOT Treatment Readiness      .07 .15 .45* .30 .42 .46* 
6. MOT Pressures for Treatment       .61** -.48* -.40 -.45* -.42* 
7. MOT Treatment Needs        -.25 -.41* -.12 -.06 
8. ENG Treatment Participation         .77** .91** .79** 
9. ENG Treatment Satisfaction          .70** .65** 
10. ENG Counseling Rapport           .80** 
11. ENG Peer Support            
Note. PGI = Patient Global Impression of Improvement scale (Trujols et al., 2011); CGI = Clinician Global Impression of 
Improvement scale (Guy, 1976; Trujols et al., 2011); MOT = TCU Client Evaluation of Motivation scale (Garner et al., 2007; Joe et 
al., 2002); ENG = TCU Client Evaluation of Treatment Engagement scale (Garner et al., 2007; Joe et al., 2002). 
*p < .05. **p < .01. ***p < .001. 
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Table 2 
 
Bivariate Correlations Between PGI, CGI, LSS, PSY, and HLTH Scales 
 
Variable 1 2 3 4 5 6 7 8 9 10 
1. PGI  .23 .29 .29 -.22 -.14 .33 .39* -.11 -.01 
2. CGI   .09 .10 -.24 -.13 .28 .28 .29 -.18 
3. LSS    .66** -.59** -.54** .42* .64** -.20 -.23 
4. PSY Self Esteem     -.79** -.60** .64** .51** -.26 -.20 
5. PSY Depression      .70** -.42* -.53** .14 .46* 
6. PSY Anxiety       -.19 -.65** .17 .45* 
7. PSY Decision Making        .22 .01 -.04 
8. PSY Expectancy         -.20 -.40 
9. HLTH Physical Health          .06 
10. HLTH Psychological Distress           
Note. PGI = Patient Global Impression of Improvement scale (Trujols et al., 2011); CGI = Clinician Global Impression of 
Improvement scale (Guy, 1976; Trujols et al., 2011); LSS = Life Situation Survey (Chubon, 1999); PSY = TCU Client Evaluation of 
Psychological Functioning (Garner et al., 2007; Joe et al., 2002); HLTH = TCU Physical and Mental Health Status Screen (Joe et al., 
2004). 
*p < .05. **p < .01. ***p < .001. 
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Table 3 
 
Bivariate Correlations Between PGI, CGI, FMFR, ALC, and CEL Scales 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. PGI  .23 .24 -.02 .26 -.21 .01 .12 -.04 -.40* -.30 
2. CGI   .05 .15 .26 -.19 -.15 -.24 -.12 -.25 -.32 
3. FMFR Family Relationships    -.18 -.00 -.00 -.21 -.01 .03 -.47* -.33 
4. FMFR Family Drug Use     .26 .24 .17 .04 -.27 .15 .05 
5. FMFR Peer Socialization      -.35 -.18 .10 .14 -.28 -.11 
6. FMFR Peer Criminality       .56** .16 -.10 .34 .41* 
7. ALC        .29 -.44* .12 .08 
8. CEL Crime Problems         .03 .04 .55** 
9. CEL Employment Problems          -.17 .37 
10. CEL Life Status Problems           .67** 
11. CEL Total            
Note. PGI = Patient Global Impression of Improvement scale (Trujols et al., 2011); CGI = Clinician Global Impression of 
Improvement scale (Guy, 1976; Trujols et al., 2011); FMFR = TCU Family and Friends Assessment (Joe et al., 2004); ALC = TCU 
Alcohol Use and Problem Symptoms (Joe et al., 2004); CEL = TCU General Crime, Employment, and Life Status (Joe et al., 2004). 
*p < .05. **p < .01. ***p < .001.
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Table 4 
 
Bivariate Correlations Between PGI, CGI, SOC and RSK Scales 
 
Variable 1 2 3 4 5 6 
1. PGI  .23 -.14 .02 -.12 -.03 
2. CGI   -.30 -.19 .19 .32 
3. SOC Hostility    .24 -.20 -.09 
4. SOC Risk Taking     -.25 -.32 
5. SOC Support      .19 
6. RSK        
Note. PGI = Patient Global Impression of Improvement scale (Trujols et al., 2011); CGI = 
Clinician Global Impression of Improvement scale (Guy, 1976; Trujols et al., 2011); SOC = 
TCU Client Evaluation of Social Functioning (Garner et al., 2007; Joe et al., 2002); RSK = TCU 
Global Risk Assessment Adult (Joe et al., 2004). 





Simple Linear Regression Analyses Predicting PGI 
 
Predictors R2 Adj. R2 β F df d 
PGI       
 PSY Expectancy .15 .18 .39 4.56* 1, 26 .84 
 CEL Life Status Problems .16 .13 -.40 4.94* 1, 26 .87 
Note. PGI = Patient Global Impression of Improvement scale (Trujols et al., 2011); PSY = TCU 
Client Evaluation of Psychological Functioning (Garner et al., 2007; Joe et al., 2002); CEL = 
TCU General Crime, Employment, and Life Status (Joe et al., 2004). 
*p < .05. **p < .01. ***p < .001. 
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Table 6 
Simple Linear Regressions Predicting POS 
Predictors R2 Adj. R2 β F df d 
POS       
 PGI .17 .14 .42 5.87* 1, 28 .91 
 CGI .14 .11 .37 4.23* 1, 26 .81 
Note. POS = Patient Opinion of Services (Pérez de los Cobos et al., 2005); PGI = Patient Global 
Impression of Improvement scale (Trujols et al., 2011); CGI = Clinician Global Impression of 
Improvement scale (Guy, 1976; Trujols et al., 2011). 
*p < .05. **p < .01. ***p < .001.
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Table 7 
Bivariate Correlations Between POS, MOT, and ENG 
Variable 1 2 3 4 5 6 7 8 9 10 
1. POS  -.56** -.25 .17 -.39 .06 .42* .36 .48* .40* 
2. MOT Problem Recognition   .60** -.06 .83** .28 -.52* -.40 -.53* -.48* 
3. MOT Desire for Help    .46* .52* .39 .15 -.08 .18 .29 
4. MOT Treatment Readiness     .07 .15 .45* .30 .42 .46* 
5. MOT Pressures for Treatment      .61** -.48* -.40 -.45* -.42* 
6. MOT Treatment Needs       -.25 -.41* -.12 -.06 
7. ENG Treatment Participation        -.77** .91** .79** 
8. ENG Treatment Satisfaction         .70** .65** 
9. ENG Counseling Rapport          .80** 
10. ENG Peer Support           
Note. POS = Patient Opinion of Services (Pérez de los Cobos et al., 2005); MOT = TCU Client Evaluation of Motivation scale 
(Garner et al., 2007; Joe et al., 2002); ENG = TCU Client Evaluation of Treatment Engagement scale (Garner et al., 2007; Joe et al., 
2002). 
*p < .05. **p < .01. ***p < .001.
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Table 8  
Simple Linear Regressions Predicting POS 
Predictors R2 Adj. R2 β F df 
POS      
 ENG Treatment Participation .18 .15 .42 5.26* 1, 24 
 ENG Counseling Rapport .233 .20 .48 7.58* 1, 25 
 ENG Peer Support .16 .13 .40 4.94* 1, 26 
 MOT Problem Recognition .311 .28 -.56 9.92** 1, 22 
Note. POS = Patient Opinion of Services (Pérez de los Cobos et al., 2005); MOT = TCU Client 
Evaluation of Motivation scale (Garner et al., 2007; Joe et al., 2002); ENG = TCU Client 
Evaluation of Treatment Engagement scale (Garner et al., 2007; Joe et al., 2002). 
*p < .05. **p < .01. ***p < .001. 
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Table 9 
 















Overall feeling about effect of program in helping deal with problems 3; 10% 11; 36.7% 3; 10% - - 
Overall feeling about all services received 9; 30% 16; 53.3% 5; 16.7% - - 
Overall feeling about personal manner of staff 17; 56.7% 8; 26.7% 5; 16.7% - - 
Overall feeling about effectiveness of program in helping to improve 
relationships with close relatives 14; 46.7% 14; 46.7% 2; 6.7% - - 
Overall feeling about effectiveness of services in helping close relatives to 
better understand problems 7; 23.3% 15; 50% 8; 26.7% - - 
Overall feeling about knowledge of nursing staff on current and past 
diseases 10; 33.3% 10; 33.3% 5; 16.7% - - 
Overall feeling about information received about diagnosis and evolution 
of addiction 6; 20% 18; 60% 6; 20% - - 
Overall feeling about effectiveness of service in helping establish good 
relationships with people outside family 7; 23.3% 16; 53.3% 6; 20% - - 
Overall feeling about instructions about what to do on own between 
appointments 5; 16.7% 15; 50% 10; 33.3% - - 
Overall feeling about effectiveness of service in helping to improve self-
care 12; 40% 13; 43.3% 4; 13.3% - - 
Overall feeling about ability of staff to listen to and understand problems 12; 40% 13; 43.3% 4; 13.3% - - 
Overall feeling about help received for side effects of methadone 9; 30% 14; 46.7% 6; 20% - - 
Overall impression about methadone as a medication for carrying out 
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Table 10 
Clients’ Opinions of Services 





















Did you receive help from staff 
to improve capacity to cope 
with social and working life? 
Yes: 20; 66.7%  No: 9; 30% 
9; 45% 9; 45% - 1; 5% -  - 2; 22.2% 6; 66.7% 
Did you have opportunity to 
take part in leisure activities 
organized by methadone 
program? 
Yes: 7; 23.3%  No: 23; 76.7% 
- 3; 42.9% 3; 42.9% - -  9; 39.1% 2; 8.7% 8; 34.8% 
Did you take part in Matrix 
program? 
Yes: 6; 20%  No: 23; 76.7% 
1; 16.7% 3; 50% 1; 16.7% - -  5; 22.7% 4; 18.2% 10; 45.5% 
Did you receive practical help at 
home from centre? 
Yes: 3; 10%  No: 26; 86.7% 
2; 66.7% 1; 3.3% - - -  4; 15.4% 6; 23.1% 13; 50% 
Did you receive help from 
centre to join leisure activities 
separate from methadone 
program? 
Yes: 6; 20%  No: 24; 80% 
2; 33.3% 2; 33.3% 1; 16.7% - -  7; 30.4% 4; 17.4% 11; 47.8% 
 
  





1. Your age: ____________ years 
 
2. Your sex:  Male________    Female _______    Other _________ 
  
3. Your ethnicity (e.g., First Nation, Cree): _______________________ 
 






Cohabiting (i.e., living with your partner) ______ 
Widowed ______ 
Other (please specify) ______________________ 
 
5. What is the highest education you have completed? 
 Less than Elementary _______ 
 Elementary Completed _______ 
 Some Junior High 
 Junior High Completed _______ 
 Some High School _______ 
 High School or GED Completed _______ 
 Some Post-Secondary _______ 
 Post-Secondary Completed _______ 
  
6. Where are you living currently? 
 With family or other relatives _______ 
 With a group of friends (or non-family members) _______ 
 Alone in your own dwelling _______ 
 Homeless _______ 
 In a hospital, rehabilitation facility, or nursing home _______ 
 In a jail, prison, or other correctional facility _______ 
 Other (specify) __________________________________________________ 
 
7. How long have you been living at that place? _____________________________ 
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8. Where were you living before you began treatment with CNTH? 
 With family or other relatives _______ 
 With a group of friends (or non-family members) _______ 
 Alone in your own dwelling _______ 
 Homeless _______ 
 In a hospital, rehabilitation facility, or nursing home _______ 
 In a jail, prison, or other correctional facility _______ 
 Other (specify) __________________________________________________ 
 
9. When did you begin treatment at Cree Nations Treatment Haven? 
 (month) _________________ (day) ________ (year) ________ 
 
10a. Are you currently part of the MATRIX program? Yes _______  No _______ 
 
 10b. When did you first enter the MATRIX program? 
  (month) _________________ (day) ________ (year) ________ 
  
 10c. When did you first complete the MATRIX program? 
  (month) _________________ (day) ________ (year) ________ 
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LSS 
 
A number of statements which concern different aspects of your PRESENT life situation 
are listed below. Read each statement and indicate the extent to which you agree or 
disagree with each statement by placing an ✗  or ✓  in the appropriate place.  
 








   
 
1. I feel safe and secure.  ......................................... !        !           !          !           !            !            
 
2. My health is good.  .............................................. !        !           !          !           !            ! 
 
3. I have too few friends who I can count on.  ........ !        !           !          !           !            ! 
 
4. I like myself the way I am.  ................................. !        !           !          !           !            ! 
 
5. I am better off than most people in my community.  . !        !           !          !           !            ! 
 
6. I feel constantly under pressure.  ........................ !        !           !          !           !            ! 
 
7. I don’t eat very well.  .......................................... !        !           !          !           !            ! 
 
8. My future is hopeless.  ........................................ !        !           !          !           !            ! 
 
9. I am a happy person.  .......................................... !        !           !          !           !            ! 
 
10. There are always people willing to help me 
      when I really need it.  ........................................ !        !           !          !           !            ! 
 
11. My income is a constant source of worry.  ....... !        !           !          !           !            ! 
 
12. My sleep is restful and refreshing.  ................... !        !           !          !           !            ! 
 
13. I don’t get the love and affection I need.  ......... !        !           !          !           !            ! 
 
14. I don’t have any fun or relaxation.  ................... !        !           !          !           !            ! 
 
15. Services provided by the government and other  
      public agencies meet my needs.  ....................... !        !           !          !           !            ! 
 




















17. I am satisfied with my main life  
      role now (for example, as a  
      worker, student, homemaker,  
      retiree, or patient)  .  .......................................... !        !           !          !           !            ! 
 
18. There is little that I am able to enjoy in my  
      community and surroundings.  .......................... !        !           !          !           !            ! 
 
19. I am exhausted well before the end of the day.  !        !           !          !           !            ! 
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TCU PSY 
 
Please indicate how much you agree or disagree with each statement based on the LAST 
MONTH. 
 
 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
1. You have trouble sleeping.  ................................ ! ! ! ! ! 
2. You have much to be proud of.  .......................... ! ! ! ! ! 
3. You consider how your actions will affect others.  ... ! ! ! ! ! 
4. You plan ahead.  ................................................. ! ! ! ! ! 
5. You feel interested in life.  .................................. ! ! ! ! ! 
6. You feel like a failure.  ....................................... ! ! ! ! ! 
7. You have trouble concentrating or  
    remembering things.  .......................................... ! ! ! ! ! 
 
8. You feel afraid of certain things, like elevators,  
    crowds, or going out alone.  ................................ ! ! ! ! ! 
 
9. You feel anxious or nervous.  ............................. ! ! ! ! ! 
 
10. You wish you had more respect for yourself.  .. ! ! ! ! ! 
 
11. You are likely to feel the need to use drugs in  
      the next few months.  ........................................ ! ! ! ! ! 
 
12. You feel sad or depressed.  ............................... ! ! ! ! ! 
 
13. You think about probable results of your  
      actions.  ............................................................. ! ! ! ! ! 
 
14. You feel extra tired or run down.  ..................... ! ! ! ! ! 
 
15. You have trouble sitting still for long.  ............. ! ! ! ! ! 
 
16. You think about what causes your current  
      problems.  .......................................................... ! ! ! ! ! 
 
17. You are likely to drink alcohol in the next  
     few months.  ....................................................... ! ! ! ! ! 
 
18. You think of several different ways to solve a  
     problem.  ............................................................ ! ! ! ! ! 
 
19. You feel you are basically no good.  ................. ! ! ! ! ! 
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 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
  
20. You worry or brood a lot.  ................................ ! ! ! ! ! 
 
21. You have trouble making decisions.  ................ ! ! ! ! ! 
  
22. You feel hopeless about the future.  .................. ! ! ! ! ! 
  
23. You make good decisions.  ............................... ! ! ! ! ! 
  
24. You are likely to relapse in the next few months. ... ! ! ! ! !   
  
25. In general, you are satisfied with yourself.  ...... ! ! ! !    !  
  
26. You make decisions without thinking about  
      consequences.  ................................................... ! ! ! ! ! 
  
27. Please fill in the “Disagree” box as your  
      response for this question.  ................................ ! ! ! ! ! 
  
28. You feel tense or keyed up.  .............................. ! ! ! ! ! 
  
29. You feel you are unimportant to others.  .......... ! ! ! ! ! 
  
30. You feel tightness or tension in your muscles.   ! ! ! ! ! 
  
31. You are likely to have problems in quitting  
      drug use.  ........................................................... ! ! ! ! ! 
  
32. You feel lonely.  ................................................ ! ! ! ! ! 
  
33. You analyze problems by looking at all the  
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TCU HLTH 
 
1. How many times in the PAST MONTH have you gone to a hospital or clinic or seen a     
    doctor or nurse for health problems? 
   
 ! None ! 1 time ! 2-3 times ! 4-10 times ! Over 10 times 
 
During the PAST MONTH, how often have you had any of these problems or types of 
diseases –  
 None A little Some Most of All of 
 of the of the of the the the 
  time time time time time  
 
 2. stomach problems or ulcers?  ........................ ! ! ! ! ! 
 3. bone/joint problems?  .................................... ! ! ! ! ! 
 4. kidney infection or problems?  ...................... ! ! ! ! ! 
 5. bladder infection or problems?  ..................... ! ! ! ! ! 
 6. liver or gall bladder problems?  ..................... ! ! ! ! ! 
 7. intestinal or bowel problems?  ....................... ! ! ! ! ! 
 8. heart disease or problems?  ............................ ! ! ! ! ! 
 9. sexually transmitted disease (STD)?  ............ ! ! ! ! ! 
 10. skin disease or skin problems?  ..................... ! ! ! ! ! 
 11. other medical or physical problems?  ............ ! ! ! ! ! 
 
During the PAST MONTH, how often did you feel –  
 
 12. tired out for no good reason?  ........................ ! ! ! ! ! 
 13. nervous?  ........................................................ ! ! ! ! ! 
 14. so nervous that nothing could calm you down?  .. ! ! ! ! ! 
 15. hopeless?  ....................................................... ! ! ! ! ! 
 16. restless or fidgety?  ........................................ ! ! ! ! ! 
 17. so restless that you could not sit still?  .......... ! ! ! ! ! 
 18. depressed?  ..................................................... ! ! ! ! ! 
 19. so depressed that nothing could cheer you up?  .. ! ! ! ! ! 
 20. that everything was an effort?  ...................... ! ! ! ! ! 





EVALUATING AN ON-RESERVE MMT PROGRAM 113 
TCU FMFR 
 
Describe your relationships with your FAMILY – that is, parents, brothers/sisters, 
grandparents, aunts/uncles, etc. – during the LAST MONTH. 
 
How strongly do you disagree or agree with the following statements? 
 
 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
1. Your family got along well together.  ................. ! ! ! ! ! 
  
2. You really enjoyed being together.  .................... ! ! ! ! ! 
 
3. Your family drank alcohol together.  .................. ! ! ! ! ! 
  
4. You got drunk together.  ..................................... ! ! ! ! ! 
  
5. You used other (illegal) drugs together.  ............ ! ! ! ! ! 
 
6. You had serious talks about each other's interests  
    and needs.  ........................................................... ! ! ! ! ! 
  
7. Your family helped each other deal with problems.  . ! ! ! ! ! 
  
8. You got blamed or fussed at about things YOU  
    did or did not do.  ................................................ ! ! ! ! ! 
  
9. You and your family often had disagreements.  . ! ! ! ! ! 
  
10. You had serious arguments or fights in your family.! ! ! ! ! 
 
 
Describe your relationships with people you consider to be your FRIENDS in the LAST  
MONTH. 
 
How strongly do you disagree or agree with the following statements? 
 
 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
11. Your friends spend time together with their  
      families eating meals or watching TV.  ............ ! ! ! ! ! 
  
12. They liked being with their families.  ............... ! ! ! ! ! 
  
13. Your friends usually worked regularly on a job.  .... ! ! ! ! ! 
  
14. They felt hopeful about their future.  ................ ! ! ! ! !  
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 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
15. They got into loud arguments or fights with  
      other people. ............. ........................................ ! ! ! ! ! 
  
16. Your friends liked to get drunk.  ....................... ! ! ! ! ! 
  
17. They used other (illegal) drugs.  ....................... ! ! ! ! ! 
  
18. They traded, sold, or dealt drugs.  ..................... ! ! ! ! ! 
  
19. Your friends did other things against the law.  . ! ! ! ! ! 
  
20. Some spent time in “gang” activities.  .............. ! ! ! !              !  
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TCU ALC 
 
Please mark answers based on drinking alcohol during the PAST MONTH. 
  
 0 1-2 3-4 5-6 7 
 
1. On average, how many days each week did you  
    drink any beer, wine, wine coolers, or hard liquor? ... ! ! ! ! ! 
 
2. On average, how many days each week did you 
    ever have 5 or more drinks in a row?  ................. ! ! ! ! ! 
 
3. On average, how many days each week did you ever  
    have 3 or more drinks within a 1-hour period?  .. ! ! ! ! ! 
 
 
 0-2 3-4 5-6 7-10 11+ 
 
4. On average, how many drinks (cans, glasses, 
    shots) did you have on each of those drinking  
    days?  .................................................................. ! ! ! ! ! 
 
 
In the LAST MONTH, did your alcohol use ever lead to… 
  .....................................................................    YES  NO 
 
5. problems getting to work or school on time, or caring for children?   ! ! 
 
6. dangers for you or others while driving or operating machinery?   ! ! 
 
7. fights or arguments with family or friends? ........    ! ! 
 
8. needing to have more drinks to feel their effects?    ! ! 
 
9. drinking early in the day to avoid having shakes or tremors?   ! ! 
 
10. having more drinks than you really wanted or intended?   ! ! 
 
11. trying without success to reduce your drinking?    ! ! 
 
12. giving over more of your time for drinking? ....    ! ! 
 
13. forgetting about meetings or events with family or friends?   ! ! 
 
14. having poor attention and concentration, or emotional troubles?  ! ! 
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TCU CEL 
 
Please mark answers based on the PAST MONTH 
  
 0 1-2 3-4 5-6 7 
 
1. On average, how many days each week did you 
    spend time while “clean and sober” doing things 
    with your family or friends? ............................... ! ! ! ! ! 
 
2. On average, how many days each week did you 
    ever attend group support (AA/NA/CA) or other 
    self-help meetings?  ............................................ ! ! ! ! ! 
 
3. On average, how many days each week did you 
    spend time hanging out with someone “high” on 
    alcohol or drugs?  ................................................ ! ! ! ! ! 
 
4. On average, how many days each week did you have  
    “no regular place” to live or spend the nights?  .. ! ! ! ! ! 
 
5. On average, how many days each week did you 
    ever get into fights or loud arguments?  .............. ! ! ! ! ! 
   
6. On average, how many days each week did you 
    spend working the “full day” on a paid job or  
    at school? ............................................................ ! ! ! ! ! 
 
7. On average, how many days each week did you 
    spend working just “part of the day” for pay, or 
    to help someone in need?  ................................... ! ! ! ! ! 
 
 
 0-2 3-4 5-6 7-10 11+ 
 
8. Altogether, how many TIMES have you 
    needed a doctor (or medical care) for an  
    injury or sickness?  .............................................. ! ! ! ! ! 
 
9. How many TIMES were you arrested (taken to 
    the police station)?  ............................................. ! ! ! ! ! 
 
10. How many TIMES were you locked up in a 
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TCU MOT 
 
Please indicate how much you agree or disagree with each statement based on the PAST 
MONTH. 
 
 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
1. You need help dealing with your drug use.  ....... ! ! ! ! ! 
  
2. You need to be in treatment now.  ...................... ! ! ! ! ! 
  
3. You have family members who want you to be  
    in treatment.  ....................................................... ! ! ! ! ! 
  
4. This treatment gives you a chance to solve your  
    drug problems.  ................................................... ! ! ! ! ! 
  
5. Your drug use is a problem for you.  .................. ! ! ! ! ! 
  
6. This kind of treatment program is not helpful to you. ! ! ! ! ! 
  
7. You need help with your emotional troubles.  .... ! ! ! ! ! 
 
8. Your drug use is more trouble than it’s worth.  .. ! ! ! ! ! 
  
9. You are concerned about legal problems.  .......... ! ! ! ! ! 
  
10. Your drug use is causing problems with the law.  ... ! ! ! ! ! 
  
11. Your drug use is causing problems in thinking  
      or doing your work.  .......................................... ! ! ! ! ! 
  
12. It is urgent that you find help immediately for  
      your drug use.  ................................................... ! ! ! ! ! 
  
13. You will give up your friends and hangouts to  
      solve your drug problems.  ................................ ! ! ! ! ! 
  
14. You feel a lot of pressure to be in treatment.  ... ! ! ! ! ! 
 
15. You need individual counseling sessions.  ....... ! ! ! ! ! 
  
16. Your drug use is causing problems with your  
      family or friends.  .............................................. ! ! ! ! ! 
  
17. You expect to be sent to jail or prison if you  
      are not in treatment.  ......................................... ! ! ! ! ! 
  
18. This treatment program gives you hope for recovery.! ! ! ! ! 
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 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
19. You need educational or vocational training 
      services.  ............................................................ ! ! ! ! !  
  
20. Your drug use is causing problems in finding or  
      keeping a job.  ................................................... ! ! ! ! ! 
  
21. You want to be in drug treatment.  ................... ! ! ! ! ! 
  
22. Your life has gone out of control.  .................... ! ! ! ! ! 
  
23. You need group counseling sessions.  .............. ! ! ! ! ! 
  
24. Your drug use is causing problems with your  
      health.  ............................................................... ! ! ! ! ! 
  
25. You are ready to leave this treatment program.  ! ! ! ! !  
  
26. You are tired of the problems caused by drugs. ! ! ! ! ! 
  
27. You are at this treatment program only because 
      it is required.  .................................................... ! ! ! ! ! 
 
28. Your drug use is making your life become worse  
      and worse.  ........................................................ ! ! ! ! ! 
  
29. You have serious drug-related health problems.! ! ! ! ! 
  
30. You want to get your life straightened out.  ...... ! ! ! ! ! 
  
31. You need medical care and services.  ............... ! ! ! ! ! 
  
32. Several people close to you have serious drug  
      problems.  .......................................................... ! ! ! ! ! 
  
33. Your drug use is going to cause your death if  
      you do not quit soon.  ........................................ ! ! ! ! ! 
  
34. You have legal problems that require you to be  
      in treatment.  ..................................................... ! ! ! ! ! 
  
35. You are not ready for this kind of treatment  
      program.  ........................................................... ! ! ! ! ! 
  
36. Please fill in the “Uncertain” box as your  
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TCU SOC 
 
Please indicate how much you agree or disagree with each statement based on the LAST 
MONTH. 
 
 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
1. You have people close to you who motivate 
     and encourage your recovery.  ........................... ! ! ! ! ! 
 
2. You have never deliberately said something that  
    hurt someone’s feelings.  .................................... ! ! ! ! ! 
  
3. You only do things that feel safe.  ...................... ! ! ! ! ! 
  
4. You are sometimes irritated by people who ask  
    favours of you.  ................................................... ! ! ! ! ! 
  
5. You have close family members who want to  
    help you stay away from drugs.  ......................... ! ! ! ! ! 
 
6. You have good friends who do not use drugs.  ... ! ! ! ! ! 
  
7. When you do not know something, you do not at  
    all mind admitting it.  .......................................... ! ! ! ! ! 
  
8. You have carried weapons like knives or guns.  . ! ! ! ! ! 
  
9. You have people close to you who can always be  
    trusted.  ................................................................ ! ! ! ! ! 
  
10. You feel a lot of anger inside you.  ................... ! ! ! ! ! 
  
11. You sometimes try to get even rather than forgive  
      and forget.  ........................................................ ! ! ! ! ! 
  
12. You have a hot temper.  .................................... ! ! ! ! ! 
  
13. You like others to feel afraid of you.  ............... ! ! ! ! ! 
  
14. You are always willing to admit it  
      when you make a mistake.  ............................... ! ! ! ! ! 
 
15. You feel mistreated by other people.  ............... ! ! ! ! ! 
  
16. You avoid anything dangerous.  ....................... ! ! ! ! ! 
  
17. You have people close to you who understand  
      your situation and problems.  ............................ ! ! ! ! ! 
  
18. You are very careful and cautious.  .................. ! ! ! ! !  
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 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
19. There have been occasions when you took  
      advantage of someone.  ..................................... ! ! ! ! !  
   
20. You work in situations where drug use is common.  ! ! ! ! ! 
  
21. You have people close to you who expect you  
      to make positive changes in your life.  ............. ! ! ! ! ! 
  
22. You can remember “playing sick” to get out of  
      something.  ........................................................ ! ! ! ! ! 
  
23. No matter who you are talking to, you are  
      always a good listener.  ..................................... ! ! ! ! ! 
  
24. You get mad at other people easily.  ................. ! ! ! ! ! 
  
25. You have people close to you who help you  
      develop confidence in yourself.  ....................... ! ! ! ! !  
 
26. You like to do things that are strange or exciting.  .. ! ! ! ! ! 
  
27. You have felt like rebelling against people in  
      authority even when they were right.  ............... ! ! ! ! ! 
  
28. You have urges to fight or hurt others.  ............ ! ! ! ! ! 
 
29. Please fill in the “Agree” box as your response  
      for this question. ............................................... ! ! ! ! ! 
  
30. You like to take chances.  ................................. ! ! ! ! ! 
  
31. You have people close to you who respect you  
      and your efforts.  ............................................... ! ! ! ! ! 
  
32. Occasionally, you gave up doing something  
      because you thought too little of your ability.  . ! ! ! ! ! 
  
33. You like the “fast” life.  .................................... ! ! ! ! ! 
  
34. You like friends who are wild.  ......................... ! ! ! ! ! 
   
35. You sometimes feel resentful when you do not  
      get your way.  .................................................... ! ! ! ! ! 
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TCU RSK 
 
Please mark answers to the series of questions listed below. 
 
1. How much of the time in the PAST MONTH were you locked up (i.e., not living in the 
‘free world”)? 
 
 ! None 
 ! Less than 1 week 
 ! 1-2 weeks 
 ! 2-4 weeks 
 
 
In the PAST MONTH were you ever –  
 
2. employed full time (35+ hrs/week)?  ............................................................................ ! No     ! Yes 
 
3. unemployed and NOT looking for work?  .................................................................... ! No     ! Yes 
  
4. receiving any public financial support (food stamps, disability, public assistance)?  .. ! No     ! Yes 
 
5. on parole or probation?  ................................................................................................ ! No     ! Yes 
 
6. treated in an emergency room?  .................................................................................... ! No     ! Yes 
 
7. treated for a mental health problem?  ........................................................................... ! No     ! Yes 
 
8. treated for an alcohol use problem?  ............................................................................. ! No     ! Yes 
 
9. treated for illegal drug use?  .......................................................................................... ! No     ! Yes 
 
10. arrested?  ..................................................................................................................... ! No     ! Yes 
 
11. in jail or prison?  ......................................................................................................... ! No     ! Yes 
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MEQ 
 
DRUG USE / HIGH RISK BEHAVIOURS  
 
1. Would you consider your drug use and high-risk behaviours have been reduced since 
admission to the CNTH methadone program? (check one) 
          ☐ Yes ☐ No 
 
HOUSING 
2. Are you homeless? (check one)     ☐ Yes ☐ No 
 
3. Do you have adequate housing? (check one)  ☐ Yes ☐ No  
 
4. Have you changed residences since admission to the CNTH methadone program? (check one)  
          ☐ Yes ☐ No 
 
5. If you have changed residence since admission, how many times? _____ 
 
6. Would you consider your housing condition has improved since admission? (check one)




7. Please select which employment status curently applies to you (check one) 
 ☐ ful-time employment   
 ☐ part-time employment 
 ☐ seasonal employment   
 ☐ homemaker 
 ☐ student     
 ☐ disabled 
 ☐ retired      
 ☐ unemployed  
 
8. Would you consider your employment status has improved since you started the program at 
CNTH? (check one)       ☐ Yes ☐ No  
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CRIMINAL CONVICTIONS 
 
9. Have you had any new criminal convictions since you started the program at CNTH? (check 
one)          ☐ Yes ☐ No 
 
10. If you have had new criminal convictions since you started the program at CNTH, how 
many? __________ 
 
11. If you had previously engaged in criminal behaviour, would you consider there has been a 
decrease in your criminal behaviour since you started the program at CNTH? (check one)  
          ☐ Yes ☐ No 
 
FAMILY 
12. Do you have family support? (check one)   ☐ Yes ☐ No 
 
13. Would you consider your family support has increased since you started the program at 
CNTH? (check one)       ☐ Yes ☐ No 
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VSSS-MT 
 
Please choose the answer which is the best description of your experience in using the Cree 
Nations Treatment Haven methadone program over the LAST MONTH: 
 
1. What is your overall feeling about the effect of the program in helping you deal with your 
problems? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
2. What is your overall feeling about, in general, all services you have received? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
3. What is your overall feeling about the personal manner of the staff? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
4. What is your overall feeling about the effectiveness of the program in helping you to improve 
your relationships with your close relatives? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
5. What is your overall feeling about the effectiveness of services in helping your close relatives 
know and better understand your problems? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  




EVALUATING AN ON-RESERVE MMT PROGRAM 125 
6. What is your overall feeling about the knowledge on the part of the nursing staff of your 
current and past diseases? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
7. What is your overall feeling about the information you received about the diagnosis and 
possible evolution of your addiction? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
8. What is your overall feeling about the effectiveness of the service in helping you establish 
good relationships with people outside your family (e.g., friends, neighbors, colleagues at work, 
etc.)? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
9. What is your overall feeling about the instructions about what to do on your own between 
appointments (e.g., the clarity, practicality etc. of recommendations)? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
 
10. What is your overall feeling about the effectiveness of the service in helping you to improve 
your self-care (e.g., taking care of your personal hygiene, your diet, your room)?  
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
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11. What is your overall feeling about the ability of the staff to listen to and understand your 
problems? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
12. What is your overall feeling about the help you have received for side effects from 
medications (if occurred), particularly methadone (e.g. constipation)? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
13a. In the last month, did you receive help from staff to improve your capacity to cope with 
your social and working life (e.g. going to public offices, doing housework, getting on with your 
family and others)? 
☐ YES (answer 13b) 
☐ NO (answer 13c) 
 
13b. If YES, what is your overall feeling about this/them? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
13c. If NO, do you think you would have liked to receive this/them? 
☐ Yes 
☐ No  
☐ Don’t know 
☐ Not applicable 
 
14a. In the last month, did you have the opportunity to take part in leisure activities organized by 
the methadone program? 
☐ YES (answer 14b) 
☐ NO (answer 14c) 
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14b. If YES, what is your overall feeling about this/them? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
14c. If NO, do you think you would have liked to receive this/them? 
☐ Yes 
☐ No  
☐ Don’t know 
☐ Not applicable 
 
15a. In the last month, did you take part in the Matrix program? 
☐ YES (answer 15b)  
☐ NO (answer 15c) 
 
15b. If YES, what is your overall feeling about this? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
15c. If NO, do you think you would have liked to take part in this? 
☐ Yes 
☐ No  
☐ Don’t know 
☐ Not applicable 
 
16a. In the last month, did you have practical help at home from the service (e.g., visits from the 
nursing staff because you were sick, help caring for your children, etc.)? 
☐ YES (answer 16b) 
☐ NO (answer 16c) 
 
16b. If YES, what is your overall feeling about this/them? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
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16c. If NO, do you think you would have liked to receive this/them? 
☐ Yes 
☐ No  
☐ Don’t know 
☐ Not applicable 
 
17a. In the last month, did you receive help from the service to join in leisure activities separate 
from the methadone program (e.g., sports clubs, adult education, etc.)? 
☐ YES (answer 17b) 
☐ NO (answer 17c) 
 
17b. If YES, what is your overall feeling about this/them? 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
☐ Mostly satisfied  
☐ Excellent 
☐ Not applicable 
 
17c. If NO, do you think you would have liked to receive this/them? 
☐ Yes 
☐ No  
☐ Don’t know 
☐ Not applicable 
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TCU ENG 
 
Please indicate how much you agree or disagree with each statement based on the LAST 
MONTH of treatment. 
 
 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
1. You trust your counselor.  ................................... ! ! ! ! ! 
 
2. Time schedules for counseling sessions at this  
    program are convenient for you.  ........................ ! ! ! ! ! 
  
3. It’s always easy to follow or understand what  
    your counselor is trying to tell you.  ................... ! ! ! ! ! 
  
4. This program expects you to learn responsibility  
    and self-discipline.  ............................................. ! ! ! ! ! 
  
5. Your counselor is easy to talk to.  ....................... ! ! ! ! ! 
  
6. You are willing to talk about your feelings  
    during counseling.  .............................................. ! ! ! ! ! 
  
7. This program is organized and run well.  ........... ! ! ! ! ! 
  
8.You are motivated and encouraged by your counselor.! ! ! ! ! 
 
9. You have made progress with your drug/alcohol  
    problems.  ............................................................ ! ! ! ! ! 
  
10. You are satisfied with this program.  ................ ! ! ! ! ! 
  
11. You have learned to analyze and plan ways to  
      solve your problems.  ........................................ ! ! ! ! ! 
  
12. You have made progress toward your treatment  
      program goals.  .................................................. ! ! ! ! ! 
  
13. You always attend the counseling sessions  
      scheduled for you.  ............................................ ! ! ! ! ! 
  
14. Your counselor recognizes the progress you  
      make in treatment.  ............................................ ! ! ! ! ! 
 
15. Your counselor is well organized and prepared  
      for each counseling session.  ............................. ! ! ! ! ! 
  
16. Your counselor is sensitive to your situation  
      and problems.  ................................................... ! ! ! ! ! 
  
17. Your treatment plan has reasonable objectives.  ! ! ! ! !  
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 Disagree    Agree 
 Strongly Disagree Uncertain Agree Strongly 
 
18. Your counselor views your problems and  
      situations realistically.  ...................................... ! ! ! ! ! 
  
19. Other clients at this program care about you and  
      your problems.  ................................................. ! ! ! ! !  
  
20. You have stopped or greatly reduced your drug  
      use while in this program.  ................................ ! ! ! ! ! 
  
21. Your counselor helps you develop confidence  
      in yourself.  ....................................................... ! ! ! ! ! 
  
22. You always participate actively in your  
      counseling sessions.  ......................................... ! ! ! ! ! 
  
23. You have made progress in understanding your  
      feelings and behavior.  ...................................... ! ! ! ! ! 
  
24. Other clients at this program are helpful to you. ! ! ! ! ! 
  
25. You have improved your relations with other  
      people because of this treatment.  ..................... ! ! ! ! !  
 
26. The staff here are efficient at doing their job.  .. ! ! ! ! ! 
  
27. You are similar to (or like) other clients of  
      this program.  .................................................... ! ! ! ! ! 
 
28. You have made progress with your emotional  
      or psychological issues.  ................................... ! ! ! ! ! 
 
29.Your counselor respects you and your opinions. ! ! ! ! ! 
 
30.You have developed positive trusting friendships  
     while in this program.  ....................................... ! ! ! ! ! 
  
31. You give honest feedback during counseling.  . ! ! ! ! ! 
  
32. You can depend on your counselor’s understanding.! ! ! ! ! 
  
33. There is a sense of family (or community) in this  
      program.  ........................................................... ! ! ! ! ! 
  
34. You can get plenty of personal counseling at this  
      program.  ........................................................... ! ! ! ! ! 
  
35. This program location is convenient for you.  .. ! ! ! ! ! 
  
36. You are following your counselor’s guidance.   ! ! ! ! ! 
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PGI 
 
Compared to your condition AT ADMISSION to the centre, how much have you changed? 
 
☐ Very much improved 
☐ Much improved 
☐ Minimally improved 
☐ No change 
☐ Minimally worse 
☐ Much worse 






Taking into account your overall experience, what is your impression about methadone as 
a medication for carrying out maintenance treatment of opioid dependence? 
 
☐ Terrible  
☐ Mostly dissatisfied  
☐ Mixed  
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PLEASE, WRITE YOUR COMMENTS 
(If you need more room, please feel free to write on the back of the page). 
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CGI 
 
Rate total improvement that, in your clinical judgment, is due entirely to drug treatment. 
 
Compared to his/her condition at baseline, how much has he/she changed? 
 
☐ Very much improved 
☐ Much improved 
☐ Minimally improved 
☐ No change 
☐ Minimally worse 
☐ Much worse 
☐ Very much worse 
 
